BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Müller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med. 1998;188:2033-2045. [PMID: 9841917 DOI: 10.1084/jem.188.11.2033] [Cited by in Crossref: 588] [Cited by in F6Publishing: 603] [Article Influence: 25.6] [Reference Citation Analysis]
Number Citing Articles
1 Lai HT, Naumova N, Marchais A, Gaspar N, Geoerger B, Brenner C. Insight into the interplay between mitochondria-regulated cell death and energetic metabolism in osteosarcoma. Front Cell Dev Biol 2022;10:948097. [DOI: 10.3389/fcell.2022.948097] [Reference Citation Analysis]
2 Ramalingam A, Mustafa N, Chng WJ, Medimagh M, Sambandam S, Issaoui N. 3-Chloro-3-methyl-2,6-diarylpiperidin-4-ones as Anti-Cancer Agents: Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET Prediction. Biomolecules 2022;12:1093. [DOI: 10.3390/biom12081093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ramalingam A, Mustafa N, Chng WJ, Medimagh M, Sambandam S, Issaoui N. 3-Chloro-3-methyl-2,6-diarylpiperidin-4-ones as Anti-Cancer Agents: Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET Prediction. Biomolecules 2022;12:1093. [DOI: 10.3390/biom12081093] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Seyrek K, Wohlfromm F, Espe J, Lavrik IN. The cross-talk of autophagy and apoptosis in breast carcinoma: implications for novel therapies? Biochem J 2022;479:1581-608. [PMID: 35904454 DOI: 10.1042/BCJ20210676] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lopez KE, Bouchier-Hayes L. Lethal and Non-Lethal Functions of Caspases in the DNA Damage Response. Cells 2022;11:1887. [PMID: 35741016 DOI: 10.3390/cells11121887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li J, Bai R, Yang W, Miao H, Li Y, Dai H, Li L, Zhao Y, Song X. The mitochondrial‐derived lncRNA MDL1 mediates a mitochondria‐to‐nucleus retrograde regulation by inhibiting the nuclear translocation of p53. MedComm – Oncology 2022;1. [DOI: 10.1002/mog2.15] [Reference Citation Analysis]
7 Dou J, Zhang Z, Xu X, Zhang X. Exploring the effects of Chinese herbal ingredients on the signaling pathway of alopecia and the screening of effective Chinese herbal compounds. J Ethnopharmacol 2022;294:115320. [PMID: 35483562 DOI: 10.1016/j.jep.2022.115320] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Panizza E, Regalado BD, Wang F, Nakano I, Vacanti NM, Cerione RA, Antonyak MA. Proteomic analysis reveals microvesicles containing NAMPT as mediators of radiation resistance in glioma.. [DOI: 10.1101/2022.03.23.485479] [Reference Citation Analysis]
9 Risso V, Lafont E, Le Gallo M. Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases. Cell Death Dis 2022;13:248. [PMID: 35301281 DOI: 10.1038/s41419-022-04688-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Lemoine J, Ruella M, Houot R. Born to survive: how cancer cells resist CAR T cell therapy. J Hematol Oncol 2021;14:199. [PMID: 34809678 DOI: 10.1186/s13045-021-01209-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
11 Shao R, Yang Y, Fan K, Wu X, Jiang R, Tang L, Li L, Shen Y, Liu G, Zhang L. REV-ERBα Agonist GSK4112 attenuates Fas-induced Acute Hepatic Damage in Mice. Int J Med Sci 2021;18:3831-8. [PMID: 34790059 DOI: 10.7150/ijms.52011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Barati M, Darvishi B, Javidi MA, Mohammadian A, Shariatpanahi SP, Eisavand MR, Madjid Ansari A. Cellular stress response to extremely low-frequency electromagnetic fields (ELF-EMF): An explanation for controversial effects of ELF-EMF on apoptosis. Cell Prolif 2021;:e13154. [PMID: 34741480 DOI: 10.1111/cpr.13154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sulejmani O, Grunewald L, Andersch L, Schwiebert S, Klaus A, Winkler A, Astrahantseff K, Eggert A, Henssen AG, Schulte JH, Anders K, Künkele A. Inhibiting Lysine Demethylase 1A Improves L1CAM-Specific CAR T Cell Therapy by Unleashing Antigen-Independent Killing via the FAS-FASL Axis. Cancers (Basel) 2021;13:5489. [PMID: 34771652 DOI: 10.3390/cancers13215489] [Reference Citation Analysis]
14 Rizzotto D, Englmaier L, Villunger A. At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity. Int J Mol Sci 2021;22:10883. [PMID: 34639222 DOI: 10.3390/ijms221910883] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
15 An G, Park H, Lim W, Song G. Fluroxypyr-1-methylheptyl ester interferes with the normal embryogenesis of zebrafish by inducing apoptosis, inflammation, and neurovascular toxicity. Comp Biochem Physiol C Toxicol Pharmacol 2021;247:109069. [PMID: 33930526 DOI: 10.1016/j.cbpc.2021.109069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chabanon RM, Rouanne M, Lord CJ, Soria JC, Pasero P, Postel-Vinay S. Targeting the DNA damage response in immuno-oncology: developments and opportunities. Nat Rev Cancer 2021. [PMID: 34376827 DOI: 10.1038/s41568-021-00386-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 45.0] [Reference Citation Analysis]
17 Lees A, Sessler T, McDade S. Dying to Survive-The p53 Paradox. Cancers (Basel) 2021;13:3257. [PMID: 34209840 DOI: 10.3390/cancers13133257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
18 Zhang Y, Shao X, Gao C, Xu D, Wu J, Zhu X, Chen Z. High FAS expression correlates with a better prognosis and efficacy of taxanes and target regents in breast cancer. Cancer Biomark 2021. [PMID: 34092611 DOI: 10.3233/CBM-203125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Renu K, Pureti LP, Vellingiri B, Valsala Gopalakrishnan A. Toxic effects and molecular mechanism of doxorubicin on different organs – an update. Toxin Reviews. [DOI: 10.1080/15569543.2021.1912099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Chatterjee M, Viswanathan P. Long noncoding RNAs in the regulation of p53-mediated apoptosis in human cancers. Cell Biol Int 2021;45:1364-82. [PMID: 33760332 DOI: 10.1002/cbin.11597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Chatterjee M, Viswanathan P. Long noncoding RNAs in the regulation of p53‐mediated apoptosis in human cancers. Cell Biology International 2021;45:1364-82. [DOI: 10.1002/cbin.11597] [Reference Citation Analysis]
22 Wang X, Lin H, Yuan D, Zhu Z, Pei L, Zhang J, Sun Y, Zhao Q. Biotherapeutic Effects of Salidroside on Gastric Carcinoma Cells. IOP Conf Ser : Earth Environ Sci 2021;690:012007. [DOI: 10.1088/1755-1315/690/1/012007] [Reference Citation Analysis]
23 Blanchet A, Bourgmayer A, Kurtz JE, Mellitzer G, Gaiddon C. Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair. Cancers (Basel) 2021;13:916. [PMID: 33671606 DOI: 10.3390/cancers13040916] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
24 Moxley AH, Reisman D. Context is key: Understanding the regulation, functional control, and activities of the p53 tumour suppressor. Cell Biochem Funct 2021;39:235-47. [PMID: 32996618 DOI: 10.1002/cbf.3590] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
25 Ganesan T, Sinniah A, Chik Z, Alshawsh MA. Punicalagin Regulates Apoptosis-Autophagy Switch via Modulation of Annexin A1 in Colorectal Cancer. Nutrients 2020;12:E2430. [PMID: 32823596 DOI: 10.3390/nu12082430] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
26 Wei L, Yang C, Wang G, Li K, Zhang Y, Guan H, Sun Z, Zhong C. Interleukin Enhancer Binding Factor 2 Regulates Cell Viability and Apoptosis of Human Brain Vascular Smooth Muscle Cells. J Mol Neurosci 2021;71:225-33. [PMID: 32748330 DOI: 10.1007/s12031-020-01638-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Patterson AM, Liu L, Sampson CH, Plett PA, Li H, Singh P, Mohammad KS, Hoggatt J, Capitano ML, Orschell CM, Pelus LM. A Single Radioprotective Dose of Prostaglandin E2 Blocks Irradiation-Induced Apoptotic Signaling and Early Cycling of Hematopoietic Stem Cells. Stem Cell Reports 2020;15:358-73. [PMID: 32735825 DOI: 10.1016/j.stemcr.2020.07.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
28 Costa EFD, Lima TRP, Lopes-Aguiar L, Nogueira GAS, Visacri MB, Quintanilha JCF, Pincinato EC, Calonga L, Mariano FV, Altemani AMAM, Altemani JMC, Moriel P, Chone CT, Ramos CD, Lima CSP. FAS and FASL variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients. Tumour Biol 2020;42:1010428320938494. [PMID: 32628088 DOI: 10.1177/1010428320938494] [Reference Citation Analysis]
29 Pandey V, Tripathi G, Kumar D, Kumar A, Dubey PK. Novel 3,4-diarylpyrazole as prospective anti-cancerous agents. Heliyon 2020;6:e04397. [PMID: 32695909 DOI: 10.1016/j.heliyon.2020.e04397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Lieschke E, Wang Z, Kelly GL, Strasser A. Discussion of some 'knowns' and some 'unknowns' about the tumour suppressor p53. J Mol Cell Biol 2019;11:212-23. [PMID: 30496435 DOI: 10.1093/jmcb/mjy077] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
31 Vieyra-Garcia PA, Wolf P. Extracorporeal Photopheresis: A Case of Immunotherapy Ahead of Its Time. Transfus Med Hemother 2020;47:226-35. [PMID: 32595427 DOI: 10.1159/000508479] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
32 Vigneswara V, Ahmed Z. The Role of Caspase-2 in Regulating Cell Fate. Cells 2020;9:E1259. [PMID: 32438737 DOI: 10.3390/cells9051259] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
33 Qin K, Hou H, Liang Y, Zhang X. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis. BMC Cancer 2020;20:328. [PMID: 32299384 DOI: 10.1186/s12885-020-06805-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 18.5] [Reference Citation Analysis]
34 Lu C, Klement JD, Yang D, Albers T, Lebedyeva IO, Waller JL, Liu K. SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth. Cancer Lett 2020;476:87-96. [PMID: 32061753 DOI: 10.1016/j.canlet.2020.02.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
35 Gugalavath S, Malla RR. Cellular and Molecular Response for Sensitising Cancer Cells and Protecting the Normal Cells from Radiation-Induced Damages. Biotechnological Applications in Human Health 2020. [DOI: 10.1007/978-981-15-3453-9_2] [Reference Citation Analysis]
36 Lees A, Mcintyre AJ, Falcone F, Crawford NT, Mccann C, Quinn GP, Roberts JZ, Sessler T, Gallagher PF, Gregg GM, Mcallister K, Mclaughlin KM, Allen WL, Holohan C, Egan LJ, Ryan AE, Labonte-wilson M, Dunne PD, Wappett M, Coyle VM, Johnston PG, Kerr EM, Longley DB, Mcdade SS. FLIP(L) determines p53 induced life or death.. [DOI: 10.1101/858688] [Reference Citation Analysis]
37 Li K, Li S, Wang D, Li X, Wu X, Liu X, Du G, Li X, Qin X, Du Y. Extraction, Characterization, Antitumor and Immunological Activities of Hemicellulose Polysaccharide from Astragalus radix Herb Residue. Molecules 2019;24:E3644. [PMID: 31601012 DOI: 10.3390/molecules24203644] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
38 Cavalcante GC, Schaan AP, Cabral GF, Santana-da-Silva MN, Pinto P, Vidal AF, Ribeiro-Dos-Santos Â. A Cell's Fate: An Overview of the Molecular Biology and Genetics of Apoptosis. Int J Mol Sci 2019;20:E4133. [PMID: 31450613 DOI: 10.3390/ijms20174133] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 21.0] [Reference Citation Analysis]
39 Liu W, Guo TF, Jing ZT, Tong QY. Repression of Death Receptor-Mediated Apoptosis of Hepatocytes by Hepatitis B Virus e Antigen. Am J Pathol 2019;189:2181-95. [PMID: 31449776 DOI: 10.1016/j.ajpath.2019.07.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
40 Xie MY, Hou LJ, Sun JJ, Zeng B, Xi QY, Luo JY, Chen T, Zhang YL. Porcine Milk Exosome MiRNAs Attenuate LPS-Induced Apoptosis through Inhibiting TLR4/NF-κB and p53 Pathways in Intestinal Epithelial Cells. J Agric Food Chem 2019;67:9477-91. [PMID: 31429552 DOI: 10.1021/acs.jafc.9b02925] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 23.7] [Reference Citation Analysis]
41 Wang X, Wang Q, Lin H, Xu B, Chang N, Chao X, Shi H, Meng B. Biotherapeutic mechanism of salidroside on gastric carcinoma cells. IOP Conf Ser : Mater Sci Eng 2019;592:012016. [DOI: 10.1088/1757-899x/592/1/012016] [Reference Citation Analysis]
42 Van Den Borg R, Leonetti A, Tiseo M, Giovannetti E, Peters GJ. Novel targeted strategies to overcome resistance in small-cell lung cancer: focus on PARP inhibitors and rovalpituzumab tesirine. Expert Rev Anticancer Ther 2019;19:461-71. [PMID: 31148500 DOI: 10.1080/14737140.2019.1624530] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
43 Lkhagvasuren K, Kim JK. Ziyuglycoside II induces caspases-dependent and caspases-independent apoptosis in human colon cancer cells. Toxicol In Vitro 2019;59:255-62. [PMID: 31029785 DOI: 10.1016/j.tiv.2019.04.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
44 Kaina B, Christmann M. DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas. DNA Repair (Amst) 2019;78:128-41. [PMID: 31039537 DOI: 10.1016/j.dnarep.2019.04.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 19.7] [Reference Citation Analysis]
45 He Y, Kaina B. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide? Int J Mol Sci 2019;20:E1562. [PMID: 30925722 DOI: 10.3390/ijms20071562] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
46 Harrington CT, Sotillo E, Robert A, Hayer KE, Bogusz AM, Psathas J, Yu D, Taylor D, Dang CV, Klein PS, Hogarty MD, Geoerger B, El-Deiry WS, Wiels J, Thomas-Tikhonenko A. Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma. Leukemia 2019;33:2429-41. [PMID: 30914792 DOI: 10.1038/s41375-019-0454-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
47 Gravett AM, Dalgleish AG, Copier J. In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells. Sci Rep 2019;9:1544. [PMID: 30733494 DOI: 10.1038/s41598-018-38190-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
48 Zhou S, Lu J, Li Y, Chen C, Cai Y, Tan G, Peng Z, Zhang Z, Dong Z, Kang T, Tang F. MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance. J Exp Clin Cancer Res 2018;37:284. [PMID: 30477538 DOI: 10.1186/s13046-018-0956-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
49 Heylmann D, Badura J, Becker H, Fahrer J, Kaina B. Sensitivity of CD3/CD28-stimulated versus non-stimulated lymphocytes to ionizing radiation and genotoxic anticancer drugs: key role of ATM in the differential radiation response. Cell Death Dis 2018;9:1053. [PMID: 30323167 DOI: 10.1038/s41419-018-1095-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
50 Lashgari A, Fauteux M, Maréchal A, Gaudreau L. Cellular Depletion of BRD8 Causes p53-Dependent Apoptosis and Induces a DNA Damage Response in Non-Stressed Cells. Sci Rep 2018;8:14089. [PMID: 30237520 DOI: 10.1038/s41598-018-32323-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
51 Tran LNK, Kichenadasse G, Sykes PJ. Combination Therapies Using Metformin and/or Valproic Acid in Prostate Cancer: Possible Mechanistic Interactions. Curr Cancer Drug Targets 2019;19:368-81. [PMID: 30039761 DOI: 10.2174/1568009618666180724111604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
52 Javvaji PK, Dhali A, Francis JR, Kolte AP, Mech A, Sathish L, Roy SC. Interleukin-7 improves in vitro maturation of ovine cumulus-oocyte complexes in a dose dependent manner. Cytokine 2019;113:296-304. [PMID: 30049453 DOI: 10.1016/j.cyto.2018.07.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
53 Chen L, Duan H, Xie F, Gao Z, Wu X, Chen F, Wu W. Tetrahydroxystilbene Glucoside Effectively Prevents Apoptosis Induced Hair Loss. Biomed Res Int 2018;2018:1380146. [PMID: 29808162 DOI: 10.1155/2018/1380146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
54 Liang Y, Mafuvadze B, Besch-Williford C, Hyder SM. A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts. Breast Cancer (Dove Med Press) 2018;10:53-67. [PMID: 29606888 DOI: 10.2147/BCTT.S156285] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
55 Nordin N, Majid NA, Othman R, Omer FAA, Nasharuddin MNA, Hashim NM. Plagioneurin B, a potent isolated compound induces apoptotic signalling pathways and cell cycle arrest in ovarian cancer cells. Apoptosis 2018;23:152-69. [DOI: 10.1007/s10495-018-1447-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
56 Al-Saeedi M, Steinebrunner N, Kudsi H, Halama N, Mogler C, Büchler MW, Krammer PH, Schemmer P, Müller M. Neutralization of CD95 ligand protects the liver against ischemia-reperfusion injury and prevents acute liver failure. Cell Death Dis 2018;9:132. [PMID: 29374146 DOI: 10.1038/s41419-017-0150-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
57 Safavi M, Shakeri R, Ardestani SK, Davoodi J, Ajdary S, Foroumadi A. Caspase-dependent apoptosis induced by two synthetic halogenated flavanones, 3′,7-dichloroflavanone and 3′,6-dichloroflavanone, on human breast and prostate cancer cells. In Vitro Cell Dev Biol -Animal 2018;54:136-46. [DOI: 10.1007/s11626-017-0209-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
58 Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ 2018;25:104-13. [PMID: 29149101 DOI: 10.1038/cdd.2017.169] [Cited by in Crossref: 509] [Cited by in F6Publishing: 534] [Article Influence: 101.8] [Reference Citation Analysis]
59 Pistritto G, Trisciuoglio D, Ceci C, Garufi A, D'Orazi G. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 2016;8:603-619. [PMID: 27019364 DOI: 10.18632/aging.100934] [Cited by in Crossref: 607] [Cited by in F6Publishing: 676] [Article Influence: 121.4] [Reference Citation Analysis]
60 Zingoni A, Fionda C, Borrelli C, Cippitelli M, Santoni A, Soriani A. Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance. Front Immunol 2017;8:1194. [PMID: 28993779 DOI: 10.3389/fimmu.2017.01194] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 14.0] [Reference Citation Analysis]
61 Ryan R, Tawfik O, Jensen RA, Anant S. Current Approaches to Diagnosis and Treatment of Ductal Carcinoma In Situ and Future Directions. Prog Mol Biol Transl Sci 2017;151:33-80. [PMID: 29096897 DOI: 10.1016/bs.pmbts.2017.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
62 Arcidiacono P, Ragonese F, Stabile A, Pistilli A, Kuligina E, Rende M, Bottoni U, Calvieri S, Crisanti A, Spaccapelo R. Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells. Eur J Nutr 2018;57:2547-69. [PMID: 28864908 DOI: 10.1007/s00394-017-1527-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
63 Miyamoto T, Tanikawa C, Yodsurang V, Zhang YZ, Imoto S, Yamaguchi R, Miyano S, Nakagawa H, Matsuda K. Identification of a p53-repressed gene module in breast cancer cells. Oncotarget 2017;8:55821-36. [PMID: 28915555 DOI: 10.18632/oncotarget.19608] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
64 Wang L, Huang D, Jiang Z, Luo Y, Norris C, Zhang M, Tian X, Tang Y. Akt3 is responsible for the survival and proliferation of embryonic stem cells. Biol Open 2017;6:850-61. [PMID: 28483982 DOI: 10.1242/bio.024505] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
65 Lee CT, Zhou Y, Roy-Choudhury K, Siamakpour-Reihani S, Young K, Hoang P, Kirkpatrick JP, Chi JT, Dewhirst MW, Horton JK. Subtype-Specific Radiation Response and Therapeutic Effect of FAS Death Receptor Modulation in Human Breast Cancer. Radiat Res 2017;188:169-80. [PMID: 28598289 DOI: 10.1667/RR14664.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
66 Kabeer FA, Rajalekshmi DS, Nair MS, Prathapan R. Molecular mechanisms of anticancer activity of deoxyelephantopin in cancer cells. Integr Med Res 2017;6:190-206. [PMID: 28664142 DOI: 10.1016/j.imr.2017.03.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
67 González R, De la Rosa ÁJ, Rufini A, Rodríguez-Hernández MA, Navarro-Villarán E, Marchal T, Pereira S, De la Mata M, Müller-Schilling M, Pascasio-Acevedo JM, Ferrer-Ríos MT, Gómez-Bravo MA, Padillo FJ, Muntané J. Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation. PLoS One 2017;12:e0174326. [PMID: 28350813 DOI: 10.1371/journal.pone.0174326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
68 Fischer M. Census and evaluation of p53 target genes. Oncogene 2017;36:3943-56. [PMID: 28288132 DOI: 10.1038/onc.2016.502] [Cited by in Crossref: 493] [Cited by in F6Publishing: 515] [Article Influence: 98.6] [Reference Citation Analysis]
69 Taniguchi Y, Kawata M, Ho Chang S, Mori D, Okada K, Kobayashi H, Sugita S, Hosaka Y, Inui H, Taketomi S, Yano F, Ikeda T, Akiyama H, Mills AA, Chung U, Tanaka S, Kawaguchi H, Saito T. Regulation of Chondrocyte Survival in Mouse Articular Cartilage by p63: REGULATION OF CHONDROCYTE SURVIVIAL BY p63. Arthritis & Rheumatology 2017;69:598-609. [DOI: 10.1002/art.39976] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
70 Bhattacharyya S, Sekar V, Majumder B, Mehrotra DG, Banerjee S, Bhowmick AK, Alam N, Mandal GK, Biswas J, Majumder PK, Murmu N. CDKN2A-p53 mediated antitumor effect of Lupeol in head and neck cancer. Cell Oncol (Dordr) 2017;40:145-55. [PMID: 28039610 DOI: 10.1007/s13402-016-0311-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
71 Oh YN, Jin S, Park HJ, Kwon HJ, Kim BW. Sorbus rufopilosa Extract Exhibits Antioxidant and Anticancer Activities by Inducing Cell Cycle Arrest and Apoptosis in Human Colon Adenocarcinoma HT29 Cells. J Cancer Prev 2016;21:249-56. [PMID: 28053959 DOI: 10.15430/JCP.2016.21.4.249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
72 Fierabracci A, Pellegrino M. The Double Role of p53 in Cancer and Autoimmunity and Its Potential as Therapeutic Target. Int J Mol Sci 2016;17:E1975. [PMID: 27897991 DOI: 10.3390/ijms17121975] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
73 Chakrabandhu K, Hueber AO. Fas Versatile Signaling and Beyond: Pivotal Role of Tyrosine Phosphorylation in Context-Dependent Signaling and Diseases. Front Immunol 2016;7:429. [PMID: 27799932 DOI: 10.3389/fimmu.2016.00429] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
74 Isaac R, Goldstein I, Furth N, Zilber N, Streim S, Boura-Halfon S, Elhanany E, Rotter V, Oren M, Zick Y. TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein response. Cell Death Differ 2017;24:132-43. [PMID: 27740623 DOI: 10.1038/cdd.2016.108] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
75 Matou-Nasri S, Rabhan Z, Al-Baijan H, Al-Eidi H, Yahya WB, Al Abdulrahman A, Almobadel N, Alsubeai M, Al Ghamdi S, Alaskar A, AlBalwi M, Alzahrani M, Alabdulkareem I. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation. Biochim Biophys Acta Mol Basis Dis 2017;1863:239-52. [PMID: 27641442 DOI: 10.1016/j.bbadis.2016.09.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
76 Bornschein J, Schlosser S, Schreyer AG, Müller-schilling M. Das hepatozelluläre Karzinom. Gastroenterologe 2016;11:368-382. [DOI: 10.1007/s11377-016-0101-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
77 Chow J, Tron VA. Molecular Aspects of Ultraviolet Radiation-Induced Apoptosis in the Skin. J Cutan Med Surg 2005;9:289-95. [DOI: 10.1177/120347540500900604] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
78 Tomicic MT, Meise R, Aasland D, Berte N, Kitzinger R, Krämer OH, Kaina B, Christmann M. Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM. Oncotarget 2015;6:33755-68. [PMID: 26418950 DOI: 10.18632/oncotarget.5274] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
79 Su Y, Wu H, Pavlosky A, Zou LL, Deng X, Zhang ZX, Jevnikar AM. Regulatory non-coding RNA: new instruments in the orchestration of cell death. Cell Death Dis 2016;7:e2333. [PMID: 27512954 DOI: 10.1038/cddis.2016.210] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 12.0] [Reference Citation Analysis]
80 Khan F, Ahmed F, Pushparaj PN, Abuzenadah A, Kumosani T, Barbour E, AlQahtani M, Gauthaman K. Ajwa Date (Phoenix dactylifera L.) Extract Inhibits Human Breast Adenocarcinoma (MCF7) Cells In Vitro by Inducing Apoptosis and Cell Cycle Arrest. PLoS One 2016;11:e0158963. [PMID: 27441372 DOI: 10.1371/journal.pone.0158963] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
81 Bhattacharya D, Singh MK, Chaudhuri S, Datta A, Chaudhuri S. T11TS Treatment Augments Apoptosis of Glioma Associated Brain Endothelial Cells, Hint Toward Anti-Angiogenic Action in Glioma: GLIOMA ENDOTHELIAL CELL APOPTOSIS BY T11TS. J Cell Physiol 2017;232:526-39. [DOI: 10.1002/jcp.25447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
82 Begović L, Antunovic M, Matic I, Furcic I, Baricevic A, Vojvoda Parcina V, Peharec Štefanić P, Nagy B, Marijanovic I. Effect of UVC radiation on mouse fibroblasts deficient for FAS-associated protein with death domain. Int J Radiat Biol 2016;92:475-82. [PMID: 27258329 DOI: 10.1080/09553002.2016.1186298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
83 Martin-Broto J, Pousa AL, de Las Peñas R, García Del Muro X, Gutierrez A, Martinez-Trufero J, Cruz J, Alvarez R, Cubedo R, Redondo A, Maurel J, Carrasco JA, López-Martin JA, Sala Á, Meana JA, Ramos R, Martinez-Serra J, Lopez-Guerrero JA, Sevilla I, Balaña C, Vaz Á, De Juan A, Alemany R, Poveda A. Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study. J Clin Oncol 2016;34:2294-302. [PMID: 27185843 DOI: 10.1200/JCO.2015.65.3329] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
84 Panich U, Sittithumcharee G, Rathviboon N, Jirawatnotai S. Ultraviolet Radiation-Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging. Stem Cells Int 2016;2016:7370642. [PMID: 27148370 DOI: 10.1155/2016/7370642] [Cited by in Crossref: 145] [Cited by in F6Publishing: 158] [Article Influence: 24.2] [Reference Citation Analysis]
85 Mody R. Targeting death receptors: is this trail still hot? Transl Pediatr 2013;2:66-9. [PMID: 26835292 DOI: 10.3978/j.issn.2224-4336.2013.02.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Garg NK, Tyagi RK, Singh B, Sharma G, Nirbhavane P, Kushwah V, Jain S, Katare OP. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1. International Journal of Pharmaceutics 2016;499:301-20. [DOI: 10.1016/j.ijpharm.2015.12.061] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 11.2] [Reference Citation Analysis]
87 Hye Khan MA, Fish B, Wahl G, Sharma A, Falck JR, Paudyal MP, Moulder JE, Imig JD, Cohen EP. Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy. Clin Sci (Lond) 2016;130:587-99. [PMID: 26772189 DOI: 10.1042/CS20150778] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
88 Hibler BP, Dusza SW, Wang SQ. Photoprotection and Skin Cancer Prevention. Principles and Practice of Photoprotection 2016. [DOI: 10.1007/978-3-319-29382-0_2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
89 Radin D, Lippa A, Patel P, Leonardi D. Lifeguard inhibition of Fas-mediated apoptosis: A possible mechanism for explaining the cisplatin resistance of triple-negative breast cancer cells. Biomed Pharmacother 2016;77:161-6. [PMID: 26796280 DOI: 10.1016/j.biopha.2015.12.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
90 Yoon MK, Ha JH, Lee MS, Chi SW. Structure and apoptotic function of p73. BMB Rep 2015;48:81-90. [PMID: 25441426 DOI: 10.5483/bmbrep.2015.48.2.255] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
91 Kalmodia S, Parameswaran S, Yang W, Barrow CJ, Krishnakumar S. Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy: An analytical technique to understand therapeutic responses at the molecular level. Sci Rep 2015;5:16649. [PMID: 26568521 DOI: 10.1038/srep16649] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
92 Acikgoz E, Guven U, Duzagac F, Uslu R, Kara M, Soner BC, Oktem G. Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells. PLoS One 2015;10:e0141090. [PMID: 26485709 DOI: 10.1371/journal.pone.0141090] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
93 Fischer M, Steiner L, Engeland K. The transcription factor p53: not a repressor, solely an activator. Cell Cycle 2014;13:3037-58. [PMID: 25486564 DOI: 10.4161/15384101.2014.949083] [Cited by in Crossref: 99] [Cited by in F6Publishing: 101] [Article Influence: 14.1] [Reference Citation Analysis]
94 Guicciardi ME, Gores GJ. Fas/FasL. Signaling Pathways in Liver Diseases 2015. [DOI: 10.1002/9781118663387.ch15] [Reference Citation Analysis]
95 Evison BJ, Sleebs BE, Watson KG, Phillips DR, Cutts SM. Mitoxantrone, More than Just Another Topoisomerase II Poison. Med Res Rev 2016;36:248-99. [PMID: 26286294 DOI: 10.1002/med.21364] [Cited by in Crossref: 92] [Cited by in F6Publishing: 96] [Article Influence: 13.1] [Reference Citation Analysis]
96 Khalife R, El-Hayek S, Tarras O, Hodroj MH, Rizk S. Antiproliferative and proapoptotic effects of topotecan in combination with thymoquinone on acute myelogenous leukemia. Clin Lymphoma Myeloma Leuk. 2014;14 Suppl:S46-S55. [PMID: 25486955 DOI: 10.1016/j.clml.2014.04.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
97 Chen L, Rashid F, Shah A, Awan HM, Wu M, Liu A, Wang J, Zhu T, Luo Z, Shan G. The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation. Proc Natl Acad Sci U S A 2015;112:10002-7. [PMID: 26216949 DOI: 10.1073/pnas.1502159112] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 10.3] [Reference Citation Analysis]
98 Saeed Y, Rehman A, Xie B, Xu J, Hong M, Hong Q, Deng Y. Astroglial U87 Cells Protect Neuronal SH-SY5Y Cells from Indirect Effect of Radiation by Reducing DNA Damage and Inhibiting Fas Mediated Apoptotic Pathway in Coculture System. Neurochem Res 2015;40:1644-54. [DOI: 10.1007/s11064-015-1642-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
99 Kuhn A, Wenzel J, Weyd H. Photosensitivity, apoptosis, and cytokines in the pathogenesis of lupus erythematosus: a critical review. Clin Rev Allergy Immunol 2014;47:148-62. [PMID: 24420508 DOI: 10.1007/s12016-013-8403-x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 9.1] [Reference Citation Analysis]
100 Cao K, Wang G, Li W, Zhang L, Wang R, Huang Y, Du L, Jiang J, Wu C, He X, Roberts AI, Li F, Rabson AB, Wang Y, Shi Y. Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity. Oncogene 2015;34:5960-70. [PMID: 25745993 DOI: 10.1038/onc.2015.46] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 7.4] [Reference Citation Analysis]
101 Pustylnyak VO, Lisachev PD, Shtark MB. Expression of p53 target genes in the early phase of long-term potentiation in the rat hippocampal CA1 area. Neural Plast 2015;2015:242158. [PMID: 25767724 DOI: 10.1155/2015/242158] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
102 Feng Z, Riopel M, Popell A, Wang R. A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase. Diabetologia 2015;58:654-65. [DOI: 10.1007/s00125-015-3504-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
103 Speidel D. The role of DNA damage responses in p53 biology. Arch Toxicol 2015;89:501-17. [PMID: 25618545 DOI: 10.1007/s00204-015-1459-z] [Cited by in Crossref: 107] [Cited by in F6Publishing: 112] [Article Influence: 15.3] [Reference Citation Analysis]
104 Giono LE, Ladelfa MF, Monte M. p53 at the Crossroads Between Stress Response Signaling and Tumorigenesis: From Molecular Mechanisms to Therapeutic Opportunities. Stress Response Pathways in Cancer 2015. [DOI: 10.1007/978-94-017-9421-3_4] [Reference Citation Analysis]
105 Liu W, Lin YT, Yan XL, Ding YL, Wu YL, Chen WN, Lin X. Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression. FASEB J 2015;29:1113-23. [PMID: 25466893 DOI: 10.1096/fj.14-263822] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
106 Berkova Z, Wang S, Ao X, Wise JF, Braun FK, Rezaeian AH, Sehgal L, Goldenberg DM, Samaniego F. CD74 interferes with the expression of fas receptor on the surface of lymphoma cells. J Exp Clin Cancer Res 2014;33:80. [PMID: 25304249 DOI: 10.1186/s13046-014-0080-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
107 Li L, Yao YC, Fang SH, Ma CQ, Cen Y, Xu ZM, Dai ZY, Li C, Li S, Zhang T, Hong HH, Qi WW, Zhou T, Li CY, Yang X, Gao GQ. Pigment epithelial-derived factor (PEDF)-triggered lung cancer cell apoptosis relies on p53 protein-driven Fas ligand (Fas-L) up-regulation and Fas protein cell surface translocation. J Biol Chem 2014;289:30785-99. [PMID: 25225287 DOI: 10.1074/jbc.M114.590000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
108 Eskander EF, Abd-Rabou AA, Mohamed MS, Yahya SM, El Sherbini A, Shaker OG. The potential impact of P53 and APO-1 genetic polymorphisms on hepatitis C genotype 4a susceptibility. Gene 2014;550:40-5. [PMID: 25108128 DOI: 10.1016/j.gene.2014.08.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
109 Bestard O, Cruzado JM, Grinyó JM. General Malignancy after Organ Transplantation. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch95] [Reference Citation Analysis]
110 Cao W, Zhang JL, Feng DY, Liu XW, Li Y, Wang LF, Yao LB, Zhang H, Zhang J. The effect of adenovirus-conjugated NDRG2 on p53-mediated apoptosis of hepatocarcinoma cells through attenuation of nucleotide excision repair capacity. Biomaterials 2014;35:993-1003. [PMID: 24383128 DOI: 10.1016/j.biomaterials.2013.09.096] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
111 Lin LT, Wu SJ, Lin CC. The Anticancer Properties and Apoptosis-inducing Mechanisms of Cinnamaldehyde and the Herbal Prescription Huang-Lian-Jie-Du-Tang ( Huáng Lián Jiě Dú Tang) in Human Hepatoma Cells. J Tradit Complement Med 2013;3:227-33. [PMID: 24716182 DOI: 10.4103/2225-4110.119732] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
112 Olsson M, Forsberg J, Zhivotovsky B. Caspase-2: the reinvented enzyme. Oncogene 2015;34:1877-82. [DOI: 10.1038/onc.2014.139] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
113 Canonico B, Campana R, Luchetti F, Arcangeletti M, Betti M, Cesarini E, Ciacci C, Vittoria E, Galli L, Papa S, Baffone W. Campylobacter jejuni cell lysates differently target mitochondria and lysosomes on HeLa cells. Apoptosis 2014;19:1225-42. [DOI: 10.1007/s10495-014-1005-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
114 Ma ZB, Xu HY, Jiang M, Yang YL, Liu LX, Li YH. Arsenic trioxide induces apoptosis of human gastrointestinal cancer cells. World J Gastroenterol 2014; 20(18): 5505-5510 [PMID: 24833880 DOI: 10.3748/wjg.v20.i18.5505] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
115 DNA Damage and the Regulation of Cell Fate. DNA Repair and Mutagenesis 2014. [DOI: 10.1128/9781555816704.ch23] [Reference Citation Analysis]
116 Peng F, Xiao X, Jiang Y, Luo K, Tian Y, Peng M, Zhang M, Xu Y, Gong G. HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122. PLoS One. 2014;9:e92998. [PMID: 24667324 DOI: 10.1371/journal.pone.0092998] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
117 Guo XX, Li Y, Sun C, Jiang D, Lin YJ, Jin FX, Lee SK, Jin YH. p53-dependent Fas expression is critical for Ginsenoside Rh2 triggered caspase-8 activation in HeLa cells. Protein Cell 2014;5:224-34. [PMID: 24622841 DOI: 10.1007/s13238-014-0027-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
118 Giussani P, Tringali C, Riboni L, Viani P, Venerando B. Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance. Int J Mol Sci 2014;15:4356-92. [PMID: 24625663 DOI: 10.3390/ijms15034356] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 8.9] [Reference Citation Analysis]
119 Bersani C, Xu LD, Vilborg A, Lui WO, Wiman KG. Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σ. Oncogene 2014;33:4407-17. [PMID: 24469038 DOI: 10.1038/onc.2013.594] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 5.5] [Reference Citation Analysis]
120 Bansal M, Kaushal N. Oxidative Stress and Carcinogenesis. Oxidative Stress Mechanisms and their Modulation 2014. [DOI: 10.1007/978-81-322-2032-9_4] [Reference Citation Analysis]
121 Siddik ZH. Apoptosis in Cancer. Cancer Drug Design and Discovery 2014. [DOI: 10.1016/b978-0-12-396521-9.00012-7] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
122 Guo M, Cao Y, Wang T, Song X, Liu Z, Zhou E, Deng X, Zhang N, Yang Z. Baicalin inhibits Staphylococcus aureus-induced apoptosis by regulating TLR2 and TLR2-related apoptotic factors in the mouse mammary glands. European Journal of Pharmacology 2014;723:481-8. [DOI: 10.1016/j.ejphar.2013.10.032] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
123 Wartlick F, Bopp A, Henninger C, Fritz G. DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013;1833:3093-103. [DOI: 10.1016/j.bbamcr.2013.08.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
124 Malki A, Ashry ESE. Quinuclidinone derivative 6 induced apoptosis in human breast cancer cells via sphingomyelinase and JNK signaling. Journal of Chemotherapy 2013;24:268-78. [DOI: 10.1179/1973947812y.0000000035] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
125 Liu JC, Guan X, Ryan JA, Rivera AG, Mock C, Agrawal V, Letai A, Lerou PH, Lahav G. High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis. Cell Stem Cell. 2013;13:483-491. [PMID: 23954752 DOI: 10.1016/j.stem.2013.07.018] [Cited by in Crossref: 111] [Cited by in F6Publishing: 96] [Article Influence: 12.3] [Reference Citation Analysis]
126 Blattmann C, Thiemann M, Stenzinger A, Christmann A, Roth E, Ehemann V, Debus J, Kulozik AE, Weichert W, Huber PE, Oertel S, Abdollahi A. Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model. Strahlenther Onkol 2013;189:957-66. [PMID: 23801068 DOI: 10.1007/s00066-013-0372-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
127 Zhang N, Wei X, Xu L. miR-150 promotes the proliferation of lung cancer cells by targeting P53. FEBS Lett 2013;587:2346-51. [PMID: 23747308 DOI: 10.1016/j.febslet.2013.05.059] [Cited by in Crossref: 86] [Cited by in F6Publishing: 97] [Article Influence: 9.6] [Reference Citation Analysis]
128 Su M, Mei Y, Sinha S. Role of the Crosstalk between Autophagy and Apoptosis in Cancer. J Oncol 2013;2013:102735. [PMID: 23840208 DOI: 10.1155/2013/102735] [Cited by in Crossref: 159] [Cited by in F6Publishing: 187] [Article Influence: 17.7] [Reference Citation Analysis]
129 Rai P, Plagov A, Lan X, Chandel N, Singh T, Lederman R, Ayasolla KR, Mathieson PW, Saleem MA, Husain M, Malhotra A, Chander PN, Singhal PC. mTOR plays a critical role in p53-induced oxidative kidney cell injury in HIVAN. Am J Physiol Renal Physiol 2013;305:F343-54. [PMID: 23678040 DOI: 10.1152/ajprenal.00135.2013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
130 Barckhausen C, Roos WP, Naumann SC, Kaina B. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair. Oncogene 2014;33:1964-74. [DOI: 10.1038/onc.2013.141] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
131 Wise JF, Berkova Z, Mathur R, Zhu H, Braun FK, Tao RH, Sabichi AL, Ao X, Maeng H, Samaniego F. Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex. Blood 2013;121:4729-39. [PMID: 23599269 DOI: 10.1182/blood-2012-12-471094] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
132 Schultz MJ, Swindall AF, Wright JW, Sztul ES, Landen CN, Bellis SL. ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells. J Ovarian Res 2013;6:25. [PMID: 23578204 DOI: 10.1186/1757-2215-6-25] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 8.0] [Reference Citation Analysis]
133 Feng Z, Riopel M, Li J, Donnelly L, Wang R. Downregulation of Fas activity rescues early onset of diabetes in c-KitWv/+ mice. American Journal of Physiology-Endocrinology and Metabolism 2013;304:E557-65. [DOI: 10.1152/ajpendo.00453.2012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
134 Ali AY, Farrand L, Kim JY, Byun S, Suh JY, Lee HJ, Tsang BK. Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum. Ann N Y Acad Sci. 2012;1271:58-67. [PMID: 23050965 DOI: 10.1111/j.1749-6632.2012.06734.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 6.9] [Reference Citation Analysis]
135 Yin Y, Stahl BC, Dewolf WC, Morgentaler A. p53 and Fas Are Sequential Mechanisms of Testicular Germ Cell Apoptosis. Journal of Andrology 2002;23:64-70. [DOI: 10.1002/jand.2002.23.1.64] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 8.3] [Reference Citation Analysis]
136 Brahim S, Aroui S, Abid K, Kenani A. Involvement of C-jun NH 2 -terminal kinase and apoptosis induced factor in apoptosis induced by deglycosylated bleomycin in laryngeal carcinoma cells. Cell Biology International 2009;33:964-70. [DOI: 10.1016/j.cellbi.2009.06.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
137 Kwon HY, Kim KS, Baik JS, Moon HI, Lee JW, Kim CH, Cho YS, Jeong YK, Lee YC. Triptolide-Mediated Apoptosis by Suppression of Focal Adhesion Kinase through Extrinsic and Intrinsic Pathways in Human Melanoma Cells. Evid Based Complement Alternat Med 2013;2013:172548. [PMID: 25945102 DOI: 10.1155/2013/172548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
138 Malyshev I. HSP70 in Carcinogenesis. Immunity, Tumors and Aging: The Role of HSP70 2013. [DOI: 10.1007/978-94-007-5943-5_6] [Reference Citation Analysis]
139 Santoni G, Caprodossi S, Farfariello V, Liberati S, Amantini C. Role of Death Receptors Belonging to the TNF Family in Capsaicin-Induced Apoptosis of Tumor Cells. Role of Capsaicin in Oxidative Stress and Cancer 2013. [DOI: 10.1007/978-94-007-6317-3_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
140 Freeman JA, Espinosa JM. The impact of post-transcriptional regulation in the p53 network. Brief Funct Genomics 2013;12:46-57. [PMID: 23242178 DOI: 10.1093/bfgp/els058] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
141 Hau A, Ceppi P, Peter ME. CD95 is part of a let-7/p53/miR-34 regulatory network. PLoS One 2012;7:e49636. [PMID: 23166734 DOI: 10.1371/journal.pone.0049636] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
142 Brahmi D, Ayed Y, Hfaiedh M, Bouaziz C, Mansour HB, Zourgui L, Bacha H. Protective effect of cactus cladode extract against cisplatin induced oxidative stress, genotoxicity and apoptosis in balb/c mice: combination with phytochemical composition. BMC Complement Altern Med 2012;12:111. [PMID: 22849573 DOI: 10.1186/1472-6882-12-111] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
143 Sullivan KD, Padilla-Just N, Henry RE, Porter CC, Kim J, Tentler JJ, Eckhardt SG, Tan AC, DeGregori J, Espinosa JM. ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53. Nat Chem Biol 2012;8:646-54. [PMID: 22660439 DOI: 10.1038/nchembio.965] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
144 Srivastava AK, Ali W, Singh R, Bhui K, Tyagi S, Al-khedhairy AA, Srivastava PK, Musarrat J, Shukla Y. Mancozeb-induced genotoxicity and apoptosis in cultured human lymphocytes. Life Sciences 2012;90:815-24. [DOI: 10.1016/j.lfs.2011.12.013] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
145 Weigand K, Brost S, Steinebrunner N, Büchler M, Schemmer P, Müller M. Ischemia/Reperfusion injury in liver surgery and transplantation: pathophysiology. HPB Surg. 2012;2012:176723. [PMID: 22693364 DOI: 10.1155/2012/176723] [Cited by in Crossref: 86] [Cited by in F6Publishing: 98] [Article Influence: 8.6] [Reference Citation Analysis]
146 Paunovic V, Carter NA, Thalhamer T, Blair D, Gordon B, Lacey E, Michie AM, Harnett MM. Immune complex-mediated co-ligation of the BCR with FcγRIIB results in homeostatic apoptosis of B cells involving Fas signalling that is defective in the MRL/Lpr model of systemic lupus erythematosus. J Autoimmun 2012;39:332-46. [PMID: 22647731 DOI: 10.1016/j.jaut.2012.04.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
147 Lee H, Haque S, Nieto J, Trott J, Inman JK, McCormick S, Chiorazzi N, Mongini PK. A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion. J Immunol 2012;188:6093-108. [PMID: 22611237 DOI: 10.4049/jimmunol.1103037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
148 Ohira T, Ando R, Okada Y, Suzuki H, Saito T, Nakazawa T, Nishihara K, Yamamoto S, Nakamura N, Tamura K. Sequence of busulfan-induced neural progenitor cell damage in the fetal rat brain. Exp Toxicol Pathol 2013;65:523-30. [PMID: 22494849 DOI: 10.1016/j.etp.2012.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
149 Mondal S, Bhattacharya K, Mallick A, Sangwan R, Mandal C. Bak compensated for Bax in p53-null cells to release cytochrome c for the initiation of mitochondrial signaling during Withanolide D-induced apoptosis. PLoS One 2012;7:e34277. [PMID: 22479585 DOI: 10.1371/journal.pone.0034277] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
150 Yang D, Torres CM, Bardhan K, Zimmerman M, McGaha TL, Liu K. Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo. J Immunol 2012;188:4441-9. [PMID: 22461695 DOI: 10.4049/jimmunol.1103035] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 6.0] [Reference Citation Analysis]
151 Wei X, Zhou L, Hu L, Huang Y. Tanshinone IIA arrests cell cycle and induces apoptosis in 786-O human renal cell carcinoma cells. Oncol Lett 2012;3:1144-8. [PMID: 22783408 DOI: 10.3892/ol.2012.626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
152 Lan YH, Chiang JH, Huang WW, Lu CC, Chung JG, Wu TS, Jhan JH, Lin KL, Pai SJ, Chiu YJ, Tsuzuki M, Yang JS. Activations of Both Extrinsic and Intrinsic Pathways in HCT 116 Human Colorectal Cancer Cells Contribute to Apoptosis through p53-Mediated ATM/Fas Signaling by Emilia sonchifolia Extract, a Folklore Medicinal Plant. Evid Based Complement Alternat Med 2012;2012:178178. [PMID: 22474491 DOI: 10.1155/2012/178178] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
153 Sullivan KD, Gallant-Behm CL, Henry RE, Fraikin JL, Espinosa JM. The p53 circuit board. Biochim Biophys Acta 2012;1825:229-44. [PMID: 22333261 DOI: 10.1016/j.bbcan.2012.01.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 52] [Article Influence: 1.8] [Reference Citation Analysis]
154 Long JS, Ryan KM. New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene. 2012;31:5045-5060. [PMID: 22310284 DOI: 10.1038/onc.2012.7] [Cited by in Crossref: 146] [Cited by in F6Publishing: 154] [Article Influence: 14.6] [Reference Citation Analysis]
155 Henry RE, Andrysik Z, París R, Galbraith MD, Espinosa JM. A DR4:tBID axis drives the p53 apoptotic response by promoting oligomerization of poised BAX. EMBO J 2012;31:1266-78. [PMID: 22246181 DOI: 10.1038/emboj.2011.498] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
156 Stegh AH. Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils. Expert Opin Ther Targets 2012;16:67-83. [PMID: 22239435 DOI: 10.1517/14728222.2011.643299] [Cited by in Crossref: 123] [Cited by in F6Publishing: 143] [Article Influence: 12.3] [Reference Citation Analysis]
157 Villa-Morales M, Fernández-Piqueras J. Targeting the Fas/FasL signaling pathway in cancer therapy. Expert Opin Ther Targets. 2012;16:85-101. [PMID: 22239437 DOI: 10.1517/14728222.2011.628937] [Cited by in Crossref: 104] [Cited by in F6Publishing: 115] [Article Influence: 10.4] [Reference Citation Analysis]
158 Zhang S, Lu Y, Peng Z. Recombinant Adenoviral-p53 Agent (Gendicine®). Recent Advances in Cancer Research and Therapy 2012. [DOI: 10.1016/b978-0-12-397833-2.00010-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
159 Sordet O, Solier S. Topoisomerases and Apoptosis. Cancer Drug Discovery and Development 2012. [DOI: 10.1007/978-1-4614-0323-4_19] [Reference Citation Analysis]
160 Bauer M, Goldstein M, Christmann M, Becker H, Heylmann D, Kaina B. Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress. Proc Natl Acad Sci U S A 2011;108:21105-10. [PMID: 22160723 DOI: 10.1073/pnas.1111919109] [Cited by in Crossref: 118] [Cited by in F6Publishing: 122] [Article Influence: 10.7] [Reference Citation Analysis]
161 Liu W, Chang L. Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway. The International Journal of Biochemistry & Cell Biology 2011;43:1708-19. [DOI: 10.1016/j.biocel.2011.08.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
162 Sivachandran N, Dawson CW, Young LS, Liu FF, Middeldorp J, Frappier L. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol. 2012;86:60-68. [PMID: 22013060 DOI: 10.1128/JVI.05623-11] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 5.6] [Reference Citation Analysis]
163 Tang W, Fan W, Liu Q, Zhang J, Qin X. The role of p53 in the response of tumor cells to sonodynamic therapy in vitro. Ultrasonics 2011;51:777-85. [DOI: 10.1016/j.ultras.2011.02.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
164 Meng XW, Peterson KL, Dai H, Schneider P, Lee SH, Zhang JS, Koenig A, Bronk S, Billadeau DD, Gores GJ, Kaufmann SH. High cell surface death receptor expression determines type I versus type II signaling. J Biol Chem 2011;286:35823-33. [PMID: 21865165 DOI: 10.1074/jbc.M111.240432] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
165 Morachis JM, Huang R, Emerson BM. Identification of kinase inhibitors that target transcription initiation by RNA polymerase II. Oncotarget 2011;2:18-28. [PMID: 21378408 DOI: 10.18632/oncotarget.212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
166 Muntané J. Harnessing tumor necrosis factor receptors to enhance antitumor activities of drugs. Chem Res Toxicol 2011;24:1610-6. [PMID: 21740002 DOI: 10.1021/tx2002349] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
167 Suzuki K, Matsubara H. Recent advances in p53 research and cancer treatment. J Biomed Biotechnol. 2011;2011:978312. [PMID: 21765642 DOI: 10.1155/2011/978312] [Cited by in Crossref: 73] [Cited by in F6Publishing: 99] [Article Influence: 6.6] [Reference Citation Analysis]
168 Lin H, Xiaoping Wang, Li S, Qiaoxia Wang. Anti-tumor effect of the Shefouweikang herbs on human gastric carcinoma grafted onto nude mice. 2011 International Conference on Remote Sensing, Environment and Transportation Engineering 2011. [DOI: 10.1109/rsete.2011.5966078] [Reference Citation Analysis]
169 Ng LT, Wu SJ. Antiproliferative Activity of Cinnamomum cassia Constituents and Effects of Pifithrin-Alpha on Their Apoptotic Signaling Pathways in Hep G2 Cells. Evid Based Complement Alternat Med 2011;2011:492148. [PMID: 20038571 DOI: 10.1093/ecam/nep220] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
170 Martínez-serra J, Maffiotte E, Martín J, Bex T, Navarro-palou M, Ros T, Plazas JM, Vögler O, Gutiérrez A, Amat JC, Ramos R, Saus C, Ginés J, Alemany R, Diaz M, Besalduch J. Yondelis® (ET-743, Trabectedin) sensitizes cancer cell lines to CD95-mediated cell death: New molecular insight into the mechanism of action. European Journal of Pharmacology 2011;658:57-64. [DOI: 10.1016/j.ejphar.2011.02.035] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
171 Argiris K, Panethymitaki C, Tavassoli M. Naturally occurring, tumor-specific, therapeutic proteins. Exp Biol Med (Maywood) 2011;236:524-36. [PMID: 21521711 DOI: 10.1258/ebm.2011.011004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
172 Tolde O, Folk P. Stress-induced expression of p53 target genes is insensitive to SNW1/SKIP downregulation. Cell Mol Biol Lett 2011;16:373-84. [PMID: 21461980 DOI: 10.2478/s11658-011-0012-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
173 Maldonado ME, Bousserouel S, Gossé F, Lobstein A, Raul F. Implicación de NF-κB y p53 en la expresión de receptores de muerte-TRAIL y apoptosis por procianidinas en células metastásicas humanas SW620. biomedica 2011;30:577. [DOI: 10.7705/biomedica.v30i4.296] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
174 Peterson LF, Mitrikeska E, Giannola D, Lui Y, Sun H, Bixby D, Malek SN, Donato NJ, Wang S, Talpaz M. p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cells. Leukemia 2011;25:761-9. [PMID: 21350558 DOI: 10.1038/leu.2011.7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
175 Dell'Orso S, Fontemaggi G, Stambolsky P, Goeman F, Voellenkle C, Levrero M, Strano S, Rotter V, Oren M, Blandino G. ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters. OMICS 2011;15:305-12. [PMID: 21332394 DOI: 10.1089/omi.2010.0084] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
176 Chopra M, Schrenk D. Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-persistent pollutants affect programmed cell death. Crit Rev Toxicol 2011;41:292-320. [PMID: 21323611 DOI: 10.3109/10408444.2010.524635] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
177 Xu B, Xu Z, Xia T, He P, Gao P, He W, Zhang M, Guo L, Niu Q, Wang A. Effects of the Fas/Fas-L pathway on fluoride-induced apoptosis in SH-SY5Y cells. Environ Toxicol 2011;26:86-92. [DOI: 10.1002/tox.20543] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
178 Malkin D. Li–Fraumeni Syndrome. In: Hammer GD, Else T, editors. Adrenocortical Carcinoma. New York: Springer; 2011. pp. 173-91. [DOI: 10.1007/978-0-387-77236-3_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
179 Gomes NP, Espinosa JM. Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes. Cell Cycle 2010;9:3428-37. [PMID: 20818159 DOI: 10.4161/cc.9.17.12998] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
180 Yu J, Kim J, Kim T, Kim B, Jang Y, Lee J. (E)-1-(3,4-dihydroxyphenethyl)-3-styrylurea inhibits proliferation of MCF-7 cells through G1 cell cycle arrest and mitochondria-mediated apoptosis. Mol Cells 2010;30:303-10. [DOI: 10.1007/s10059-010-0119-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
181 Chakraborty A, Kumar P, Ghosh K, Roy P. Evaluation of a Schiff base copper complex compound as potent anticancer molecule with multiple targets of action. Eur J Pharmacol 2010;647:1-12. [PMID: 20797395 DOI: 10.1016/j.ejphar.2010.08.003] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 6.6] [Reference Citation Analysis]
182 Lu B, Hu M, Liu K, Peng J. Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction. Toxicol In Vitro 2010;24:1482-90. [PMID: 20656010 DOI: 10.1016/j.tiv.2010.07.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
183 Hu F, Gartenhaus RB, Eichberg D, Liu Z, Fang H, Rapoport AP. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. Oncogene 2010;29:5464-74. [DOI: 10.1038/onc.2010.275] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 6.8] [Reference Citation Analysis]
184 Gomes NP, Espinosa JM. Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding. Genes Dev 2010;24:1022-34. [PMID: 20478995 DOI: 10.1101/gad.1881010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 6.3] [Reference Citation Analysis]
185 Wu W, Wang HD, Guo W, Yang K, Zhao YP, Jiang YG, He P. Up-regulation of Fas reverses cisplatin resistance of human small cell lung cancer cells. J Exp Clin Cancer Res 2010;29:49. [PMID: 20470393 DOI: 10.1186/1756-9966-29-49] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
186 Meley D, Spiller DG, White MR, McDowell H, Pizer B, Sée V. p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma. Cell Death Dis 2010;1:e41. [PMID: 21364648 DOI: 10.1038/cddis.2010.16] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
187 Mundt HM, Stremmel W, Melino G, Krammer PH, Schilling T, Müller M. Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways. Biochem Biophys Res Commun. 2010;396:335-341. [PMID: 20403333 DOI: 10.1016/j.bbrc.2010.04.093] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
188 Mahmood Z, Shukla Y. Death receptors: Targets for cancer therapy. Experimental Cell Research 2010;316:887-99. [DOI: 10.1016/j.yexcr.2009.12.011] [Cited by in Crossref: 132] [Cited by in F6Publishing: 135] [Article Influence: 11.0] [Reference Citation Analysis]
189 Liang Y, Besch-Williford C, Benakanakere I, Thorpe PE, Hyder SM. Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors. Breast Cancer Res Treat 2011;125:407-20. [PMID: 20349129 DOI: 10.1007/s10549-010-0851-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
190 Seitz SJ, Schleithoff ES, Koch A, Schuster A, Teufel A, Staib F, Stremmel W, Melino G, Krammer PH, Schilling T, Müller M. Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway. Int J Cancer 2010;126:2049-66. [PMID: 19711344 DOI: 10.1002/ijc.24861] [Cited by in Crossref: 7] [Cited by in F6Publishing: 40] [Article Influence: 0.6] [Reference Citation Analysis]
191 Phillips DC, Dias HI, Kitas GD, Griffiths HR. Aberrant Reactive Oxygen and Nitrogen Species Generation in Rheumatoid Arthritis (RA): Causes and Consequences for Immune Function, Cell Survival, and Therapeutic Intervention. Antioxidants & Redox Signaling 2010;12:743-85. [DOI: 10.1089/ars.2009.2607] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 6.4] [Reference Citation Analysis]
192 Schilling T, Kairat A, Melino G, Krammer PH, Stremmel W, Oren M, Müller M. Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma. Biochem Biophys Res Commun 2010;394:817-23. [PMID: 20233581 DOI: 10.1016/j.bbrc.2010.03.082] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
193 Drost J, Mantovani F, Tocco F, Elkon R, Comel A, Holstege H, Kerkhoven R, Jonkers J, Voorhoeve PM, Agami R, Del Sal G. BRD7 is a candidate tumour suppressor gene required for p53 function. Nat Cell Biol 2010;12:380-9. [PMID: 20228809 DOI: 10.1038/ncb2038] [Cited by in Crossref: 159] [Cited by in F6Publishing: 167] [Article Influence: 13.3] [Reference Citation Analysis]
194 Verheij M, Vens C, van Triest B. Novel therapeutics in combination with radiotherapy to improve cancer treatment: Rationale, mechanisms of action and clinical perspective. Drug Resistance Updates 2010;13:29-43. [DOI: 10.1016/j.drup.2010.01.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
195 Khader M, Bresgen N, Eckl P. Antimutagenic effects of ethanolic extracts from selected Palestinian medicinal plants. Journal of Ethnopharmacology 2010;127:319-24. [DOI: 10.1016/j.jep.2009.11.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
196 Rivas C, Aaronson SA, Munoz-Fontela C. Dual Role of p53 in Innate Antiviral Immunity. Viruses 2010;2:298-313. [PMID: 21994612 DOI: 10.3390/v2010298] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 6.3] [Reference Citation Analysis]
197 Verma AK. Transgenic Mouse Models to Investigate Functional Specificity of Protein Kinase C Isoforms in the Development of Squamous Cell Carcinoma, a Nonmelanoma Human Skin Cancer. Protein Kinase C in Cancer Signaling and Therapy 2010. [DOI: 10.1007/978-1-60761-543-9_15] [Reference Citation Analysis]
198 Guicciardi ME, Gores GJ. Fas/FasL. Signaling Pathways in Liver Diseases 2010. [DOI: 10.1007/978-3-642-00150-5_11] [Reference Citation Analysis]
199 Miyata S, Takemura G, Kosai K, Takahashi T, Esaki M, Li L, Kanamori H, Maruyama R, Goto K, Tsujimoto A, Takeyama T, Kawaguchi T, Ohno T, Nishigaki K, Fujiwara T, Fujiwara H, Minatoguchi S. Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis. Am J Pathol 2010;176:687-98. [PMID: 20035047 DOI: 10.2353/ajpath.2010.090222] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
200 Nalam RL, Andreu-Vieyra C, Braun RE, Akiyama H, Matzuk MM. Retinoblastoma protein plays multiple essential roles in the terminal differentiation of Sertoli cells. Mol Endocrinol 2009;23:1900-13. [PMID: 19819985 DOI: 10.1210/me.2009-0184] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
201 Tomicic MT, Christmann M, Kaina B. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage. J Pharmacol Exp Ther 2010;332:316-25. [PMID: 19812371 DOI: 10.1124/jpet.109.159962] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
202 Qian J, Zhang JS, Wang XQ, Ji JL, Mei S. Fenretinide stimulates the apoptosis of hepatic stellate cells and ameliorates hepatic fibrosis in mice. Hepatol Res. 2009;39:1229-1247. [PMID: 19788699 DOI: 10.1111/j.1872-034X.2009.00562.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
203 Schilling T, Schleithoff ES, Kairat A, Melino G, Stremmel W, Oren M, Krammer PH, Müller M. Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family. Biochemical and Biophysical Research Communications 2009;387:399-404. [DOI: 10.1016/j.bbrc.2009.07.063] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
204 Gagiannis S, Müller M, Uhlemann S, Koch A, Melino G, Krammer PH, Nawroth PP, Brune M, Schilling T. Parathyroid hormone-related protein confers chemoresistance by blocking apoptosis signaling via death receptors and mitochondria. Int J Cancer 2009;125:1551-7. [PMID: 19507249 DOI: 10.1002/ijc.24471] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
205 Wu SJ, Chang SP, Lin DL, Wang SS, Hou FF, Ng LT. Supercritical carbon dioxide extract of Physalis peruviana induced cell cycle arrest and apoptosis in human lung cancer H661 cells. Food Chem Toxicol 2009;47:1132-8. [PMID: 19425186 DOI: 10.1016/j.fct.2009.01.044] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
206 Wang B, Xiao Z, Ren EC. Redefining the p53 response element. Proc Natl Acad Sci U S A 2009;106:14373-8. [PMID: 19597154 DOI: 10.1073/pnas.0903284106] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 6.8] [Reference Citation Analysis]
207 Cotter TG. Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer. 2009;9:501-507. [PMID: 19550425 DOI: 10.1038/nrc2663] [Cited by in Crossref: 534] [Cited by in F6Publishing: 562] [Article Influence: 41.1] [Reference Citation Analysis]
208 Amantini C, Ballarini P, Caprodossi S, Nabissi M, Morelli MB, Lucciarini R, Cardarelli MA, Mammana G, Santoni G. Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis 2009;30:1320-9. [DOI: 10.1093/carcin/bgp138] [Cited by in Crossref: 105] [Cited by in F6Publishing: 107] [Article Influence: 8.1] [Reference Citation Analysis]
209 Wang GY, Lv QH, Dong Q, Xu RZ, Dong QH. Berbamine induces Fas-mediated apoptosis in human hepatocellular carcinoma HepG2 cells and inhibits its tumor growth in nude mice. J Asian Nat Prod Res. 2009;11:219-228. [PMID: 19408145 DOI: 10.1080/10286020802675076] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
210 Cai C, Feng L, Wang L, Kong Q, Zhao Y. Tetrazolium violet induces apoptosis via caspases-8, -9 activation and Fas/FasL up-regulation in Rat C6 glioma cells. Arch Pharm Res 2009;32:575-81. [DOI: 10.1007/s12272-009-1414-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
211 Dudgeon C, Qiu W, Sun Q, Zhang L, Yu J. Transcriptional Regulation of Apoptosis. In: Dong Z, Yin X, editors. Essentials of Apoptosis. Totowa: Humana Press; 2009. pp. 239-60. [DOI: 10.1007/978-1-60327-381-7_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
212 Olsson M, Vakifahmetoglu H, Abruzzo PM, Högstrand K, Grandien A, Zhivotovsky B. DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis. Oncogene 2009;28:1949-59. [PMID: 19347032 DOI: 10.1038/onc.2009.36] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 5.2] [Reference Citation Analysis]
213 Rampias T, Sasaki C, Weinberger P, Psyrri A. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst. 2009;101:412-423. [PMID: 19276448 DOI: 10.1093/jnci/djp017] [Cited by in Crossref: 190] [Cited by in F6Publishing: 199] [Article Influence: 14.6] [Reference Citation Analysis]
214 Kanemitsu H, Yamauchi H, Komatsu M, Yamamoto S, Okazaki S, Uchida K, Nakayama H. 6-mercaptopurine (6-MP) induces p53-mediated apoptosis of neural progenitor cells in the developing fetal rodent brain. Neurotoxicol Teratol 2009;31:198-202. [PMID: 19281843 DOI: 10.1016/j.ntt.2009.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
215 Almendro V, Ametller E, García-Recio S, Collazo O, Casas I, Augé JM, Maurel J, Gascón P. The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin. PLoS One 2009;4:e4728. [PMID: 19266094 DOI: 10.1371/journal.pone.0004728] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
216 Johal H, Scott GM, Jones R, Camaris C, Riordan S, Rawlinson WD. Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis. J Hepatol 2009;50:548-54. [PMID: 19168254 DOI: 10.1016/j.jhep.2008.10.026] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
217 Ma G, Shimada H, Hiroshima K, Tada Y, Suzuki N, Tagawa M. Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China. Drug Des Devel Ther 2009;2:115-22. [PMID: 19920899 DOI: 10.2147/dddt.s3535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 18] [Article Influence: 0.2] [Reference Citation Analysis]
218 Aziz MH, Sundling KE, Dreckschmidt NE, Verma AK. Protein kinase Cepsilon inhibits UVR-induced expression of FADD, an adaptor protein, linked to both Fas- and TNFR1-mediated apoptosis. J Invest Dermatol 2009;129:2011-21. [PMID: 19194472 DOI: 10.1038/jid.2008.458] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
219 Wang X, Huang G, Mei S, Qian J, Ji J, Zhang J. Over-expression of C/EBP-alpha induces apoptosis in cultured rat hepatic stellate cells depending on p53 and peroxisome proliferator-activated receptor-gamma. Biochem Biophys Res Commun. 2009;380:286-291. [PMID: 19168033 DOI: 10.1016/j.bbrc.2009.01.060] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
220 Guicciardi ME, Gores GJ. The Death Receptor Pathway. Essentials of Apoptosis 2009. [DOI: 10.1007/978-1-60327-381-7_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
221 Symes JC, Siatskas C, Fowler DH, Medin JA. Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells. Cancer Gene Ther 2009;16:439-52. [PMID: 19096446 DOI: 10.1038/cgt.2008.96] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
222 Blomberg J, Ruuth K, Jacobsson M, Höglund A, Nilsson JA, Lundgren E. Reduced FAS transcription in clones of U937 cells that have acquired resistance to Fas-induced apoptosis: Fas resistance caused by reduced transcription. FEBS Journal 2009;276:497-508. [DOI: 10.1111/j.1742-4658.2008.06790.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
223 Chang GC, Yu CT, Tsai CH, Tsai JR, Chen JC, Wu CC, Wu WJ, Hsu SL. An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells. Eur J Pharmacol 2008;600:37-44. [PMID: 18973751 DOI: 10.1016/j.ejphar.2008.10.024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
224 Peng Z, Yu Q, Zhu J. Recombinant Adenoviral-p53 Agent for Treatment of Cancers. Gene and Cell Therapy 2008. [DOI: 10.1201/9780849387999.ch49] [Reference Citation Analysis]
225 Dinu I, Potter JD, Mueller T, Liu Q, Adewale AJ, Jhangri GS, Einecke G, Famulski KS, Halloran P, Yasui Y. Gene-set analysis and reduction. Brief Bioinform 2009;10:24-34. [PMID: 18836208 DOI: 10.1093/bib/bbn042] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 5.0] [Reference Citation Analysis]
226 Fujita M, Mizuta Y, Ikegame S, Ouchi H, Ye Q, Harada E, Inoshima I, Yoshimi M, Watanabe K, Nakanishi Y. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics 2008;21:805-11. [DOI: 10.1016/j.pupt.2008.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
227 Beurel E, Blivet-Van Eggelpoël MJ, Kornprobst M, Moritz S, Delelo R, Paye F, Housset C, Desbois-Mouthon C. Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells. Biochem Pharmacol. 2009;77:54-65. [PMID: 18938143 DOI: 10.1016/j.bcp.2008.09.026] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
228 Batista LFZ, Kaina B, Meneghini R, Menck CFM. How DNA lesions are turned into powerful killing structures: insights from UV-induced apoptosis. Mutat Res 2009;681:197-208. [PMID: 18845270 DOI: 10.1016/j.mrrev.2008.09.001] [Cited by in Crossref: 142] [Cited by in F6Publishing: 149] [Article Influence: 10.1] [Reference Citation Analysis]
229 Liu N, Wang L, Li X, Yang Q, Liu X, Zhang J, Zhang J, Wu Y, Ji S, Zhang Y, Yang A, Han H, Yao L. N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis. Nucleic Acids Res 2008;36:5335-49. [PMID: 18689861 DOI: 10.1093/nar/gkn504] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 4.9] [Reference Citation Analysis]
230 Movassagh M, Foo RS. Simplified apoptotic cascades. Heart Fail Rev 2008;13:111-9. [PMID: 18080749 DOI: 10.1007/s10741-007-9070-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 4.0] [Reference Citation Analysis]
231 Muñoz-Fontela C, Macip S, Martínez-Sobrido L, Brown L, Ashour J, García-Sastre A, Lee SW, Aaronson SA. Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med 2008;205:1929-38. [PMID: 18663127 DOI: 10.1084/jem.20080383] [Cited by in Crossref: 162] [Cited by in F6Publishing: 167] [Article Influence: 11.6] [Reference Citation Analysis]
232 Wu Y, Xing D, Liu L, Gao B. Regulation of Bax activation and apoptotic response to UV irradiation by p53 transcription-dependent and -independent pathways. Cancer Letters 2008;271:231-9. [DOI: 10.1016/j.canlet.2008.06.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
233 Sproll KC, Balló H, Hoffmann TK, Scheckenbach K, Koldovsky U, Balz V, Hafner D, Ramp U, Bier H. Is there a role for the Fas-/Fas-Ligand pathway in chemoresistance of human squamous cell carcinomas of the head and neck (SCCHN)? Oral Oncol 2009;45:69-84. [PMID: 18620901 DOI: 10.1016/j.oraloncology.2008.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
234 Park IH, Kim MK, Kim SU. Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation. Biochem Biophys Res Commun 2008;377:1025-30. [PMID: 18558085 DOI: 10.1016/j.bbrc.2008.06.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
235 Thind TS, Agrawal SK, Saxena AK, Arora S. Studies on cytotoxic, hydroxyl radical scavenging and topoisomerase inhibitory activities of extracts of Tabernaemontana divaricata (L.) R.Br. ex Roem. and Schult. Food Chem Toxicol 2008;46:2922-7. [PMID: 18577413 DOI: 10.1016/j.fct.2008.05.036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
236 Kuribayashi K, El-Deiry WS. Regulation of programmed cell death by the p53 pathway. Adv Exp Med Biol. 2008;615:201-221. [PMID: 18441595 DOI: 10.1007/978-1-4020-6554-5_10] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 4.6] [Reference Citation Analysis]
237 Pan M, Hsieh M, Kuo J, Lai C, Wu H, Sang S, Ho C. 6-Shogaol induces apoptosis in human colorectal carcinoma cellsviaROS production, caspase activation, and GADD 153 expression. Mol Nutr Food Res 2008;52:527-37. [DOI: 10.1002/mnfr.200700157] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 8.8] [Reference Citation Analysis]
238 MacKenzie SH, Clark AC. Targeting cell death in tumors by activating caspases. Curr Cancer Drug Targets 2008;8:98-109. [PMID: 18336192 DOI: 10.2174/156800908783769391] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 4.7] [Reference Citation Analysis]
239 Hrstka R, Powell DJ, Kvardova V, Roubalova E, Bourougaa K, Candeias MM, Sova P, Zak F, Fåhraeus R, Vojtesek B. The novel platinum(IV) complex LA-12 induces p53 and p53/47 responses that differ from the related drug, cisplatin. Anti-Cancer Drugs 2008;19:369-79. [DOI: 10.1097/cad.0b013e3282f7f500] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
240 Yamauchi H, Katayama K, Ueno M, He XJ, Mikami T, Uetsuka K, Doi K, Nakayama H. Essential role of p53 in trophoblastic apoptosis induced in the developing rodent placenta by treatment with a DNA-damaging agent. Apoptosis 2007;12:1743-54. [PMID: 17594519 DOI: 10.1007/s10495-007-0099-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
241 Tomicic MT, Christmann M, Kaina B. Apoptosis in UV-C light irradiated p53 wild-type, apaf-1 and p53 knockout mouse embryonic fibroblasts: interplay of receptor and mitochondrial pathway. Apoptosis 2005;10:1295-304. [PMID: 16215690 DOI: 10.1007/s10495-005-1392-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
242 Shetty G, Shao SH, Weng CC. p53-dependent apoptosis in the inhibition of spermatogonial differentiation in juvenile spermatogonial depletion (Utp14bjsd) mice. Endocrinology 2008;149:2773-81. [PMID: 18356279 DOI: 10.1210/en.2007-1338] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
243 Wang Y, He QY, Tsao SW, Cheung YH, Wong A, Chiu JF. Cytokeratin 8 silencing in human nasopharyngeal carcinoma cells leads to cisplatin sensitization. Cancer Lett. 2008;265:188-196. [PMID: 18353540 DOI: 10.1016/j.canlet.2008.02.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
244 Baumann S, Fas SC, Giaisi M, Müller WW, Merling A, Gülow K, Edler L, Krammer PH, Li-weber M. Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1- and Ca2+-dependent apoptosis. Blood 2008;111:2354-63. [DOI: 10.1182/blood-2007-06-096198] [Cited by in Crossref: 111] [Cited by in F6Publishing: 118] [Article Influence: 7.9] [Reference Citation Analysis]
245 Pan M, Gao J, Lai C, Wang Y, Chen W, Lo C, Wang M, Dushenkov S, Ho C. Antitumor activity of 3,5,4′-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice. Mol Carcinog 2008;47:184-96. [DOI: 10.1002/mc.20352] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
246 Brooks CL, Gu W. Post-translational Modifications of the p53 Transcription Factor. Gene Expression and Regulation. [DOI: 10.1007/978-0-387-40049-5_15] [Reference Citation Analysis]
247 Huang C-, Hsu P-, Hung Y-, Liao Y-, Liu C-, Hour C-, Kao M-, Tsay GJ, Hung H-, Liu GY. Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production. Apoptosis 2005;10:895-907. [PMID: 16133879 DOI: 10.1007/s10495-005-2947-z] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 4.5] [Reference Citation Analysis]
248 Wu S, Ng L. MAPK inhibitors and pifithrin-alpha block cinnamaldehyde-induced apoptosis in human PLC/PRF/5 cells. Food and Chemical Toxicology 2007;45:2446-53. [DOI: 10.1016/j.fct.2007.05.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
249 Zhang L, Zambon AC, Vranizan K, Pothula K, Conklin BR, Insel PA. Gene expression signatures of cAMP/protein kinase A (PKA)-promoted, mitochondrial-dependent apoptosis. Comparative analysis of wild-type and cAMP-deathless S49 lymphoma cells. J Biol Chem 2008;283:4304-13. [PMID: 18048352 DOI: 10.1074/jbc.M708673200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
250 Chen CA, Lo CK, Lin BL, Sibley E, Tang SC. Application of doxorubicin-induced rAAV2-p53 gene delivery in combined chemotherapy and gene therapy for hepatocellular carcinoma. Cancer Biol Ther 2008;7:303-9. [PMID: 18059187 DOI: 10.4161/cbt.7.2.5333] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
251 Kook SH, Son YO, Chung SW, Lee SA, Kim JG, Jeon YM, Lee JC. Caspase-independent death of human osteosarcoma cells by flavonoids is driven by p53-mediated mitochondrial stress and nuclear translocation of AIF and endonuclease G. Apoptosis. 2007;12:1289-1298. [PMID: 17356895 DOI: 10.1007/s10495-007-0056-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
252 Zhang D, Fan D. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expert Rev Anticancer Ther. 2007;7:1369-1378. [PMID: 17944563 DOI: 10.1586/14737140.7.10.1369] [Cited by in Crossref: 74] [Cited by in F6Publishing: 83] [Article Influence: 4.9] [Reference Citation Analysis]
253 Reimann M, Schmitt CA. Apoptosis and Cancer Therapy. Apoptosis, Cell Signaling, and Human Diseases. [DOI: 10.1007/978-1-59745-200-7_13] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
254 Souhir B, Laurent P, Sonia Y, Delphine M, Marion C, Cédric R, Olivier M, Abderraouf K, Ali B. Deglycosylated bleomycin induces apoptosis in lymphoma cell via c-jun NH2-terminal kinase but not reactive oxygen species. Biochemical Pharmacology 2007;74:1445-55. [DOI: 10.1016/j.bcp.2007.07.036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
255 Sordet O, Pommier Y, Solary E. Topoisomerase I Poisons and Apoptotic Topoisomerase I-DNA Complexes. Cancer Drug Discovery and Development. [DOI: 10.1007/978-1-59745-221-2_20] [Reference Citation Analysis]
256 Bourdon J, Lane DP. p53 Family Pathway in Cancer. The Cancer Handbook 2007. [DOI: 10.1002/9780470025079.chap223] [Reference Citation Analysis]
257 Liedtke C, Lambertz D, Schnepel N, Trautwein C. Molecular mechanism of Mitomycin C-dependent caspase-8 regulation: implications for apoptosis and synergism with interferon-α signalling. Apoptosis 2007;12:2259-70. [DOI: 10.1007/s10495-007-0145-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
258 Szöke D, Györffy A, Surowiak P, Tulassay Z, Dietel M, Györffy B. Identification of consensus genes and key regulatory elements in 5-fluorouracil resistance in gastric and colon cancer. Onkologie 2007;30:421-6. [PMID: 17848813 DOI: 10.1159/000104490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
259 Verbrugge I, de Vries E, Tait SW, Wissink EH, Walczak H, Verheij M, Borst J. Ionizing radiation modulates the TRAIL death-inducing signaling complex, allowing bypass of the mitochondrial apoptosis pathway. Oncogene 2008;27:574-84. [PMID: 17684487 DOI: 10.1038/sj.onc.1210696] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
260 Brown L, Ongusaha PP, Kim HG, Nuti S, Mandinova A, Lee JW, Khosravi-Far R, Aaronson SA, Lee SW. CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner. EMBO J 2007;26:3410-22. [PMID: 17599062 DOI: 10.1038/sj.emboj.7601779] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
261 Melnikova VO, Ananthaswamy HN. p53 Protein and Nonmelanoma Skin Cancer. Medical Intelligence Unit. [DOI: 10.1007/0-387-35098-5_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
262 Chhipa RR, Bhat MK. Bystander killing of breast cancer MCF-7 cells by MDA-MB-231 cells exposed to 5-fluorouracil is mediated via Fas. J Cell Biochem 2007;101:68-79. [PMID: 17340621 DOI: 10.1002/jcb.21153] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
263 Peshes-Yaloz N, Rosen D, Sondel PM, Krammer PH, Berke G. Up-regulation of Fas (CD95) expression in tumour cells in vivo. Immunology 2007;120:502-11. [PMID: 17343612 DOI: 10.1111/j.1365-2567.2006.02521.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
264 Okazaki T, Sakamuro D. Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system. J Cancer Res Clin Oncol 2007;133:581-8. [DOI: 10.1007/s00432-007-0201-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
265 Xian M, Ito K, Nakazato T, Shimizu T, Chen CK, Yamato K, Murakami A, Ohigashi H, Ikeda Y, Kizaki M. Zerumbone, a bioactive sesquiterpene, induces G2/M cell cycle arrest and apoptosis in leukemia cells via a Fas- and mitochondria-mediated pathway. Cancer Sci 2007;98:118-26. [PMID: 17129359 DOI: 10.1111/j.1349-7006.2006.00362.x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 88] [Article Influence: 5.5] [Reference Citation Analysis]
266 Roos WP, Christmann M, Fraser ST, Kaina B. Mouse embryonic stem cells are hypersensitive to apoptosis triggered by the DNA damage O(6)-methylguanine due to high E2F1 regulated mismatch repair. Cell Death Differ. 2007;14:1422-1432. [PMID: 17464330 DOI: 10.1038/sj.cdd.4402136] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 3.7] [Reference Citation Analysis]
267 Sundelin K, Roberg K, Grénman R, Håkansson L. Effects of cisplatin, alpha-interferon, and 13-cis retinoic acid on the expression of Fas (CD95), intercellular adhesion molecule-1 (ICAM-1), and epidermal growth factor receptor (EGFR) in oral cancer cell lines. J Oral Pathol Med 2007;36:177-83. [PMID: 17305640 DOI: 10.1111/j.1600-0714.2006.00503.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
268 Guicciardi ME, Gores GJ. FasL and Fas in Liver Homeostasis and Hepatic Injuries. Fas Signaling. [DOI: 10.1007/0-387-34573-6_8] [Reference Citation Analysis]
269 Schavolt KL, Pietenpol JA. p53 and Delta Np63 alpha differentially bind and regulate target genes involved in cell cycle arrest, DNA repair and apoptosis. Oncogene 2007;26:6125-32. [PMID: 17404570 DOI: 10.1038/sj.onc.1210441] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
270 Graf E, Schneider K, Nicholson G, Ströbele M, Jones AL, Goodfellow M, Beil W, S¨ssmuth RD, Fiedler H. Elloxazinones A and B, New Aminophenoxazinones from Streptomyces griseus Acta 2871†. J Antibiot 2007;60:277-84. [DOI: 10.1038/ja.2007.35] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
271 Wilson TR, Longley DB, Johnston PG. Chemoresistance in solid tumours. Ann Oncol. 2006;17 Suppl 10:x315-x324. [PMID: 17018746 DOI: 10.1093/annonc/mdl280] [Cited by in Crossref: 124] [Cited by in F6Publishing: 130] [Article Influence: 8.3] [Reference Citation Analysis]
272 Lau WM, Ho TH, Hui KM. p16INK4A-silencing augments DNA damage-induced apoptosis in cervical cancer cells. Oncogene. 2007;26:6050-6060. [PMID: 17369842 DOI: 10.1038/sj.onc.1210405] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
273 Brenes O, Arce F, Gätjens-Boniche O, Díaz C. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Biomed Pharmacother 2007;61:347-55. [PMID: 17399942 DOI: 10.1016/j.biopha.2007.02.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
274 Floros KV, Talieri M, Scorilas A. Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Biol Chem 2006;387:1629-33. [PMID: 17132110 DOI: 10.1515/BC.2006.203] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
275 Borralho PM, Moreira da Silva IB, Aranha MM, Albuquerque C, Nobre Leitão C, Steer CJ, Rodrigues CM. Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2007;1772:40-7. [DOI: 10.1016/j.bbadis.2006.09.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
276 Tomasetti M, Neuzil J. Vitamin E Analogues and Immune Response in Cancer Treatment. Vitamin E. Elsevier; 2007. pp. 463-91. [DOI: 10.1016/s0083-6729(07)76018-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
277 Payton KS, Sheldon RA, Mack DW, Zhu C, Blomgren K, Ferriero DM, Northington FJ. Antioxidant Status Alters Levels of Fas-Associated Death Domain-Like IL-1B-Converting Enzyme Inhibitory Protein following Neonatal Hypoxia-Ischemia. Dev Neurosci 2007;29:403-11. [DOI: 10.1159/000105481] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
278 Fujimuro M, Inoue H, Teishikata Y, Ishida Y, Yokosawa H. Apoptotic effect of ganciclovir on primary effusion lymphoma cells infected with Kaposi's sarcoma-associated herpesvirus. Nucleosides Nucleotides Nucleic Acids 2006;25:635-45. [PMID: 16838851 DOI: 10.1080/15257770600686311] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
279 Damrot J, Nübel T, Epe B, Roos WP, Kaina B, Fritz G. Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide. Br J Pharmacol 2006;149:988-97. [PMID: 17088865 DOI: 10.1038/sj.bjp.0706953] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 3.8] [Reference Citation Analysis]
280 Nam C, Yamauchi H, Nakayama H, Doi K. Etoposide induces apoptosis and cell cycle arrest of neuroepithelial cells in a p53-related manner. Neurotoxicology and Teratology 2006;28:664-72. [DOI: 10.1016/j.ntt.2006.09.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
281 Zhu Q, Liu J, Yang C, Xu H, Zhang A, Cui Y, Wang H, Qin C, Li Y. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells: . European Journal of Gastroenterology & Hepatology 2006;18:1071-7. [DOI: 10.1097/01.meg.0000231750.68513.6c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
282 Liu T, Laurell C, Selivanova G, Lundeberg J, Nilsson P, Wiman KG. Hypoxia induces p53-dependent transactivation and Fas/CD95-dependent apoptosis. Cell Death Differ 2007;14:411-21. [DOI: 10.1038/sj.cdd.4402022] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
283 Avila MA, Berasain C, Sangro B, Prieto J. New therapies for hepatocellular carcinoma. Oncogene. 2006;25:3866-3884. [PMID: 16799628 DOI: 10.1038/sj.onc.1209550] [Cited by in Crossref: 281] [Cited by in F6Publishing: 308] [Article Influence: 17.6] [Reference Citation Analysis]
284 Fulda S, Debatin K. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006;25:4798-811. [DOI: 10.1038/sj.onc.1209608] [Cited by in Crossref: 1537] [Cited by in F6Publishing: 1611] [Article Influence: 96.1] [Reference Citation Analysis]
285 Hubert A, Paris S, Piret JP, Ninane N, Raes M, Michiels C. Casein kinase 2 inhibition decreases hypoxia-inducible factor-1 activity under hypoxia through elevated p53 protein level. J Cell Sci. 2006;119:3351-3362. [PMID: 16882692 DOI: 10.1242/jcs.03069] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
286 Irwin M, Malkin D. Li–Fraumeni syndrome and the p53 tumor suppressor pathway. Russell & Rubinstein's Pathology of Tumors of the Nervous System 7Ed 2006. [DOI: 10.1201/b13439-62] [Reference Citation Analysis]
287 Yamada T, Maruyama M, Fujita T, Miyabayashi K, Shinoda C, Kawagishi Y, Fujishita T, Hayashi R, Miwa T, Arai N, Matsui S, Sugiyama E, Kobayashi M. Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activation. FEBS Lett 2006;580:4387-91. [PMID: 16844116 DOI: 10.1016/j.febslet.2006.07.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
288 Roos WP, Batista LFZ, Naumann SC, Wick W, Weller M, Menck CFM, Kaina B. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene 2007;26:186-97. [DOI: 10.1038/sj.onc.1209785] [Cited by in Crossref: 351] [Cited by in F6Publishing: 374] [Article Influence: 21.9] [Reference Citation Analysis]
289 Eichhorst ST. Modulation of apoptosis as a target for liver disease. Expert Opin Ther Targets. 2005;9:83-99. [PMID: 15757484 DOI: 10.1517/14728222.9.1.83] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
290 Kwon Y, Kim K. Octahedral Pt(IV) complex K101 induces apoptosis via ERK1/2 activation and the p53 pathway in human colon cancer cells: . Anti-Cancer Drugs 2006;17:553-8. [DOI: 10.1097/00001813-200606000-00009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
291 Mueller S, Holdenrieder S, Stieber P, Haferlach T, Schalhorn A, Braess J, Nagel D, Seidel D. Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments. BMC Cancer. 2006;6:143. [PMID: 16734907 DOI: 10.1186/1471-2407-6-143] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
292 Chow J, Tron VA. Molecular Aspects of Ultraviolet Radiation-induced Apoptosis in the Skin. J Cutan Med Surg 2005;9:289-95. [DOI: 10.1007/s10227-005-0109-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
293 De Angelis PM, Svendsrud DH, Kravik KL, Stokke T. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer. 2006;5:20. [PMID: 16709241 DOI: 10.1186/1476-4598-5-20] [Cited by in Crossref: 133] [Cited by in F6Publishing: 149] [Article Influence: 8.3] [Reference Citation Analysis]
294 Hougardy BM, Maduro JH, van der Zee AG, de Groot DJ, van den Heuvel FA, de Vries EG, de Jong S. Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis. Int J Cancer 2006;118:1892-900. [PMID: 16287099 DOI: 10.1002/ijc.21580] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
295 Tyteca S, Vandromme M, Legube G, Chevillard-Briet M, Trouche D. Tip60 and p400 are both required for UV-induced apoptosis but play antagonistic roles in cell cycle progression. EMBO J 2006;25:1680-9. [PMID: 16601686 DOI: 10.1038/sj.emboj.7601066] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 4.3] [Reference Citation Analysis]
296 Du A, Zhao B, Miao J, Yin D, Zhang S. Safrole oxide induces apoptosis by up-regulating Fas and FasL instead of integrin β4 in A549 human lung cancer cells. Bioorganic & Medicinal Chemistry 2006;14:2438-45. [DOI: 10.1016/j.bmc.2005.11.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
297 Chipuk JE, Green DR. Dissecting p53-dependent apoptosis. Cell Death Differ 2006;13:994-1002. [DOI: 10.1038/sj.cdd.4401908] [Cited by in Crossref: 322] [Cited by in F6Publishing: 334] [Article Influence: 20.1] [Reference Citation Analysis]
298 Nair VD. Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson’s disease. Apoptosis 2006;11:955-66. [DOI: 10.1007/s10495-006-6316-3] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 4.0] [Reference Citation Analysis]
299 Martin LJ, Chen K, Liu Z. Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation. J Neurosci 2005;25:6449-59. [PMID: 16000635 DOI: 10.1523/JNEUROSCI.0911-05.2005] [Cited by in Crossref: 116] [Cited by in F6Publishing: 122] [Article Influence: 7.3] [Reference Citation Analysis]
300 Akimoto M, Yoshikawa M, Ebara M, Sato T, Fukuda H, Kondo F, Saisho H. Relationship between therapeutic efficacy of arterial infusion chemotherapy and expression of P-glycoprotein and p53 protein in advanced hepatocellular carcinoma. World J Gastroenterol 2006; 12(6): 868-873 [PMID: 16521213 DOI: 10.3748/wjg.v12.i6.868] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
301 Bowen JM, Gibson RJ, Cummins AG, Keefe DMK. Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support Care Cancer 2006;14:713-31. [DOI: 10.1007/s00520-005-0004-7] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 5.4] [Reference Citation Analysis]
302 Liedtke C, Gröger N, Manns MP, Trautwein C. Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells. J Hepatol 2006;44:342-9. [PMID: 16225956 DOI: 10.1016/j.jhep.2005.07.020] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
303 Hamaguchi T, Matsuoka Y, Bechberger J, Ohnishi T, Fujita K, Naus CC, Kusunoki M, Tsubura A, Tsuda H. Establishment of an apoptosis-sensitive rat mammary carcinoma cell line with a mutation in the DNA-binding region of p53. Cancer Letters 2006;232:279-88. [DOI: 10.1016/j.canlet.2005.02.043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
304 Iwano S, Shibahara N, Saito T, Kamataki T. Activation of p53 as a causal step for atherosclerosis induced by polycyclic aromatic hydrocarbons. FEBS Letters 2006;580:890-3. [DOI: 10.1016/j.febslet.2006.01.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
305 Bishop A, Kosaras B, Hollander M, Fornace A, Sidman R, Schiestl R. p21 controls patterning but not homologous recombination in RPE development. DNA Repair 2006;5:111-20. [DOI: 10.1016/j.dnarep.2005.08.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
306 Son Y, Kook S, Choi K, Jang Y, Jeon Y, Kim J, Lee K, Kim J, Chung M, Chung G, Lee J. Quercetin, a bioflavonoid, accelerates TNF-α-induced growth inhibition and apoptosis in MC3T3-E1 osteoblastic cells. European Journal of Pharmacology 2006;529:24-32. [DOI: 10.1016/j.ejphar.2005.10.041] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
307 Koslowski R, Fichtner F, Barth K, Roehlecke C, Seidel D, Kasper M. Apoptosis and release of CD44s in bleomycin-treated L132 cells. J Cell Biochem 2005;95:1146-56. [PMID: 15844216 DOI: 10.1002/jcb.20483] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
308 Bremer E, ten Cate B, Samplonius DF, de Leij LF, Helfrich W. CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia. Blood 2006;107:2863-70. [PMID: 16332967 DOI: 10.1182/blood-2005-07-2929] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.4] [Reference Citation Analysis]
309 Wallach-Dayan SB, Izbicki G, Cohen PY, Gerstl-Golan R, Fine A, Breuer R. Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathway. Am J Physiol Lung Cell Mol Physiol 2006;290:L790-6. [PMID: 16306138 DOI: 10.1152/ajplung.00300.2004] [Cited by in Crossref: 142] [Cited by in F6Publishing: 146] [Article Influence: 8.4] [Reference Citation Analysis]
310 Peng Z. Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther. 2005;16:1016-1027. [PMID: 16149900 DOI: 10.1089/hum.2005.16.1016] [Cited by in Crossref: 289] [Cited by in F6Publishing: 308] [Article Influence: 17.0] [Reference Citation Analysis]
311 Mauz-Körholz C, Banning U, Körholz D. Regulation of interleukin-2 induced soluble Fas ligand release from human peripheral blood mononuclear cells. Immunol Invest. 2004;33:251-260. [PMID: 15195700 DOI: 10.1081/IMM-120030916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
312 Rachek LI, Grishko VI, Ledoux SP, Wilson GL. Role of nitric oxide-induced mtDNA damage in mitochondrial dysfunction and apoptosis. Free Radic Biol Med. 2006;40:754-762. [PMID: 16520228 DOI: 10.1016/j.freeradbiomed.2005.09.028] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
313 Selassie CD, Kapur S, Verma RP, Rosario M. Cellular Apoptosis and Cytotoxicity of Phenolic Compounds:  A Quantitative Structure−Activity Relationship Study. J Med Chem 2005;48:7234-42. [DOI: 10.1021/jm050567w] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 4.4] [Reference Citation Analysis]
314 Sun S. Chemopreventive agent-induced modulation of death receptors. Apoptosis 2005;10:1203-10. [DOI: 10.1007/s10495-005-2274-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
315 Massari D, Trobonjač Z, Rukavina D, Radošević-stašić B. SMS 201-995 enhances S-phase block induced by 5-fluorouracil in a human colorectal cancer cell line. Anti-Cancer Drugs 2005;16:989-96. [DOI: 10.1097/01.cad.0000180118.93535.2b] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
316 Müller M, Schilling T, Sayan AE, Kairat A, Lorenz K, Schulze-Bergkamen H, Oren M, Koch A, Tannapfel A, Stremmel W, Melino G, Krammer PH. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ 2005;12:1564-77. [PMID: 16195739 DOI: 10.1038/sj.cdd.4401774] [Cited by in Crossref: 135] [Cited by in F6Publishing: 143] [Article Influence: 7.9] [Reference Citation Analysis]
317 Hwang JM, Kuo HC, Tseng TH, Liu JY, Chu CY. Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Arch Toxicol. 2006;80:62-73. [PMID: 16189662 DOI: 10.1007/s00204-005-0014-8] [Cited by in Crossref: 151] [Cited by in F6Publishing: 133] [Article Influence: 8.9] [Reference Citation Analysis]
318 O’brien DI, Nally K, Kelly RG, O’connor TM, Shanahan F, O’connell J. Targeting the Fas/Fas ligand pathway in cancer. Expert Opinion on Therapeutic Targets 2005;9:1031-44. [DOI: 10.1517/14728222.9.5.1031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
319 Zhang HM, Yuan J, Cheung P, Chau D, Wong BW, McManus BM, Yang D. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Mol Cell Biol 2005;25:6247-58. [PMID: 15988033 DOI: 10.1128/MCB.25.14.6247-6258.2005] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 3.0] [Reference Citation Analysis]
320 Tacke F, Liedtke C, Bocklage S, Manns MP, Trautwein C. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter. Gut 2005;54:1309-17. [PMID: 15871998 DOI: 10.1136/gut.2005.065086] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
321 Guicciardi ME, Gores GJ. The Fas/FasL Signaling Pathway. Signaling Pathways in Liver Diseases. [DOI: 10.1007/3-540-27194-5_11] [Reference Citation Analysis]
322 di Pietro A, Vries EG, Gietema JA, Spierings DC, de Jong S. Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. Int J Biochem Cell Biol 2005;37:2437-56. [PMID: 16099193 DOI: 10.1016/j.biocel.2005.06.014] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
323 Nakashima N, Kuwano K, Maeyama T, Hagimoto N, Yoshimi M, Hamada N, Yamada M, Nakanishi Y. The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. J Clin Pathol 2005;58:583-9. [PMID: 15917407 DOI: 10.1136/jcp.2004.022632] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
324 Woo G, Bak E, Nakayama H, Doi K. Hydroxyurea (HU)-induced apoptosis in the mouse fetal lung. Experimental and Molecular Pathology 2005;79:59-67. [DOI: 10.1016/j.yexmp.2005.02.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
325 Bank MI, Gudbrand C, Rengtved P, Carstensen H, Fadeel B, Henter JI, Petersen BL. Immunohistochemical detection of the apoptosis-related proteins FADD, FLICE, and FLIP in Langerhans cell histiocytosis. J Pediatr Hematol Oncol 2005;27:301-6. [PMID: 15956881 DOI: 10.1097/01.mph.0000168725.57143.52] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
326 Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrándiz C, Garcia Diez A, Tebbs V, McRae S. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005;152:939-47. [PMID: 15888150 DOI: 10.1111/j.1365-2133.2005.06486.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 184] [Article Influence: 10.1] [Reference Citation Analysis]
327 Yang L. Disfunction of the Apoptotic Pathway in Cancer Cells. Application of Apoptosis to Cancer Treatment. [DOI: 10.1007/1-4020-3302-8_1] [Reference Citation Analysis]
328 Hougardy BM, van der Zee AG, van den Heuvel FA, Timmer T, de Vries EG, de Jong S. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid. Gynecol Oncol 2005;97:353-64. [PMID: 15863130 DOI: 10.1016/j.ygyno.2005.01.036] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
329 Guicciardi ME, Gores GJ. Apoptosis: a mechanism of acute and chronic liver injury. Gut 2005;54:1024-33. [PMID: 15951554 DOI: 10.1136/gut.2004.053850] [Cited by in Crossref: 339] [Cited by in F6Publishing: 368] [Article Influence: 19.9] [Reference Citation Analysis]
330 Yoshimoto Y, Kawada M, Ikeda D, Ishizuka M. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo. Int Immunopharmacol. 2005;5:281-288. [PMID: 15652759 DOI: 10.1016/j.intimp.2004.09.032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
331 Yu J, Zhang L. The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 2005;331:851-8. [PMID: 15865941 DOI: 10.1016/j.bbrc.2005.03.189] [Cited by in Crossref: 310] [Cited by in F6Publishing: 326] [Article Influence: 18.2] [Reference Citation Analysis]
332 Atten MJ, Godoy-Romero E, Attar BM, Milson T, Zopel M, Holian O. Resveratrol regulates cellular PKC alpha and delta to inhibit growth and induce apoptosis in gastric cancer cells. Invest New Drugs. 2005;23:111-119. [PMID: 15744586 DOI: 10.1007/s10637-005-5855-8] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 4.2] [Reference Citation Analysis]
333 Gressner O, Schilling T, Lorenz K, Schulze Schleithoff E, Koch A, Schulze-Bergkamen H, Lena AM, Candi E, Terrinoni A, Catani MV, Oren M, Melino G, Krammer PH, Stremmel W, Müller M. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 2005;24:2458-71. [PMID: 15944736 DOI: 10.1038/sj.emboj.7600708] [Cited by in Crossref: 194] [Cited by in F6Publishing: 199] [Article Influence: 11.4] [Reference Citation Analysis]
334 Katayama K, Ueno M, Yamauchi H, Nagata T, Nakayama H, Doi K. Ethylnitrosourea induces neural progenitor cell apoptosis after S-phase accumulation in a p53-dependent manner. Neurobiol Dis. 2005;18:218-225. [PMID: 15649712 DOI: 10.1016/j.nbd.2004.09.015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
335 Igney FH, Krammer PH. Tumor counterattack: fact or fiction. Cancer Immunol Immunother. 2005;54:1127-1136. [PMID: 15889255 DOI: 10.1007/s00262-005-0680-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
336 Wei X, Xu H, Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell. 2005;7:167-178. [PMID: 15710329 DOI: 10.1016/j.ccr.2005.01.008] [Cited by in Crossref: 178] [Cited by in F6Publishing: 195] [Article Influence: 10.5] [Reference Citation Analysis]
337 Mahidhara RS, Queiroz De Oliveira PE, Kohout J, Beer DG, Lin J, Watkins SC, Robbins PD, Hughes SJ. Altered trafficking of Fas and subsequent resistance to Fas-mediated apoptosis occurs by a wild-type p53 independent mechanism in esophageal adenocarcinoma. J Surg Res. 2005;123:302-311. [PMID: 15680394 DOI: 10.1016/j.jss.2004.08.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
338 Kornblau SM, Konopleva M, Andreeff M. Apoptosis regulating proteins as targets of therapy for haematological malignancies. Expert Opinion on Investigational Drugs 2005;8:2027-57. [DOI: 10.1517/13543784.8.12.2027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
339 Mohr L, Geissler M, Blum HE. Gene therapy for malignant liver disease. Expert Opinion on Biological Therapy 2005;2:163-75. [DOI: 10.1517/14712598.2.2.163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
340 Fulda S, Debatin KM. Exploiting death receptor signaling pathways for tumor therapy. Biochim Biophys Acta 2004;1705:27-41. [PMID: 15585171 DOI: 10.1016/j.bbcan.2004.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 0.5] [Reference Citation Analysis]
341 Chen GG, Lai PB, Merchant JL. Role of p53 and ZBP-89 in Hepatocellular Carcinoma. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas, Volume 3 - Molecular Genetics, Liver Carcinoma, and Pancreatic Carcinoma 2005. [DOI: 10.1016/s1874-5784(05)80021-2] [Reference Citation Analysis]
342 Chandrasekaran Y, Richburg JH. The p53 Protein Influences the Sensitivity of Testicular Germ Cells to Mono-(2-Ethylhexyl) Phthalate-Induced Apoptosis by Increasing the Membrane Levels of Fas and DR5 and Decreasing the Intracellular Amount of c-FLIP1. Biology of Reproduction 2005;72:206-13. [DOI: 10.1095/biolreprod.104.030858] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
343 Windebank AJ, Mcdonald ES. Neurotrophic Factors in the Peripheral Nervous System. Peripheral Neuropathy. Elsevier; 2005. pp. 377-86. [DOI: 10.1016/b978-0-7216-9491-7.50020-x] [Cited by in Crossref: 11] [Article Influence: 0.6] [Reference Citation Analysis]
344 Meyers M, Hwang A, Wagner MW, Boothman DA. Role of DNA mismatch repair in apoptotic responses to therapeutic agents. Environ Mol Mutagen 2004;44:249-64. [PMID: 15468331 DOI: 10.1002/em.20056] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
345 Semont A, Nowak EB, Silva Lages C, Mathieu C, Mouthon MA, May E, Allemand I, Millet P, Boussin FD. Involvement of p53 and Fas/CD95 in murine neural progenitor cell response to ionizing irradiation. Oncogene 2004;23:8497-508. [PMID: 15361846 DOI: 10.1038/sj.onc.1207821] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
346 Bucciantini M, Rigacci S, Berti A, Pieri L, Cecchi C, Nosi D, Formigli L, Chiti F, Stefani M. Patterns of cell death triggered in two different cell lines by HypF-N prefibrillar aggregates. FASEB J 2005;19:437-9. [PMID: 15604358 DOI: 10.1096/fj.04-3086fje] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
347 Porta C, Hadj-slimane R, Nejmeddine M, Pampin M, Tovey MG, Espert L, Alvarez S, Chelbi-alix MK. Interferons α and γ induce p53-dependent and p53-independent apoptosis, respectively. Oncogene 2005;24:605-15. [DOI: 10.1038/sj.onc.1208204] [Cited by in Crossref: 70] [Cited by in F6Publishing: 76] [Article Influence: 3.9] [Reference Citation Analysis]
348 Beurel E, Kornprobst M, Blivet-Van Eggelpoël MJ, Ruiz-Ruiz C, Cadoret A, Capeau J, Desbois-Mouthon C. GSK-3beta inhibition by lithium confers resistance to chemotherapy-induced apoptosis through the repression of CD95 (Fas/APO-1) expression. Exp Cell Res. 2004;300:354-364. [PMID: 15475000 DOI: 10.1016/j.yexcr.2004.08.001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 2.7] [Reference Citation Analysis]
349 Wang L, Bowman L, Lu Y, Rojanasakul Y, Mercer RR, Castranova V, Ding M. Essential role of p53 in silica-induced apoptosis. Am J Physiol Lung Cell Mol Physiol 2005;288:L488-96. [PMID: 15557088 DOI: 10.1152/ajplung.00123.2003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
350 Rzeski W, Pruskil S, Macke A, Felderhoff-Mueser U, Reiher AK, Hoerster F, Jansma C, Jarosz B, Stefovska V, Bittigau P, Ikonomidou C. Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol 2004;56:351-60. [PMID: 15349862 DOI: 10.1002/ana.20185] [Cited by in Crossref: 81] [Cited by in F6Publishing: 88] [Article Influence: 4.5] [Reference Citation Analysis]
351 Alexia C, Fallot G, Lasfer M, Schweizer-Groyer G, Groyer A. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem Pharmacol 2004;68:1003-15. [PMID: 15313394 DOI: 10.1016/j.bcp.2004.05.029] [Cited by in Crossref: 137] [Cited by in F6Publishing: 121] [Article Influence: 7.6] [Reference Citation Analysis]
352 Fujita K, Matsuda E, Sekine K, Iigo M, Tsuda H. Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat. Cancer Letters 2004;213:21-9. [DOI: 10.1016/j.canlet.2004.03.029] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
353 Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:928-942. [PMID: 15234026 DOI: 10.1016/j.ijrobp.2004.03.005] [Cited by in Crossref: 669] [Cited by in F6Publishing: 582] [Article Influence: 37.2] [Reference Citation Analysis]
354 Aref S, Salama O, Al-Tonbary Y, Mansour A. Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia. Hematology 2004;9:113-21. [PMID: 15203866 DOI: 10.1080/1024533042000205496] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
355 Jiang M, Yi X, Hsu S, Wang CY, Dong Z. Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity. Am J Physiol Renal Physiol 2004;287:F1140-7. [PMID: 15315938 DOI: 10.1152/ajprenal.00262.2004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 140] [Article Influence: 7.1] [Reference Citation Analysis]
356 Erster S, Mihara M, Kim RH, Petrenko O, Moll UM. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol. 2004;24:6728-6741. [PMID: 15254240 DOI: 10.1128/mcb.24.15.6728-6741.2004] [Cited by in Crossref: 277] [Cited by in F6Publishing: 290] [Article Influence: 15.4] [Reference Citation Analysis]
357 Wrighton KH, Prêle CM, Sunters A, Yeudall WA. Aberrant p53 alters DNA damage checkpoints in response to cisplatin: Downregulation of CDK expression and activity: Checkpoint Alteration by Aberrant p53. Int J Cancer 2004;112:760-70. [DOI: 10.1002/ijc.20446] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
358 Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells. Biochem Pharmacol. 2004;68:293-303. [PMID: 15194001 DOI: 10.1016/j.bcp.2004.03.036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
359 Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the p53 network. J Cell Sci. 2003;116:4077-4085. [PMID: 12972501 DOI: 10.1242/jcs.00739] [Cited by in Crossref: 799] [Cited by in F6Publishing: 1031] [Article Influence: 44.4] [Reference Citation Analysis]
360 Hofmann TG, Will H. Body language: the function of PML nuclear bodies in apoptosis regulation. Cell Death Differ. 2003;10:1290-1299. [PMID: 12934066 DOI: 10.1038/sj.cdd.4401313] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 4.6] [Reference Citation Analysis]
361 Ruiz de Almodóvar C, López-Rivas A, Redondo JM, Rodríguez A. Transcriptional regulation of the TRAIL-R3 gene. Vitam Horm 2004;67:51-63. [PMID: 15110171 DOI: 10.1016/S0083-6729(04)67004-X] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
362 Yamauchi H, Katayama K, Ueno M, Uetsuka K, Nakayama H, Doi K. Involvement of p53 in 1-β-d-arabinofuranosylcytosine-induced rat fetal brain lesions. Neurotoxicology and Teratology 2004;26:579-86. [DOI: 10.1016/j.ntt.2004.03.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
363 Werner AB, Tait SW, de Vries E, Eldering E, Borst J. Requirement for Aspartate-cleaved Bid in Apoptosis Signaling by DNA-damaging Anti-cancer Regimens. Journal of Biological Chemistry 2004;279:28771-80. [DOI: 10.1074/jbc.m400268200] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
364 Min YJ, Lee JH, Choi SJ, Chi HS, Lee JS, Kim WK, Lee KH. Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia. Leuk Res 2004;28:359-65. [PMID: 15109535 DOI: 10.1016/j.leukres.2003.08.015] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
365 Curtin JF, Cotter TG. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cell Signal. 2003;15:983-992. [PMID: 14499341 DOI: 10.1016/s0898-6568(03)00093-7] [Cited by in Crossref: 136] [Cited by in F6Publishing: 141] [Article Influence: 7.6] [Reference Citation Analysis]
366 Huang ST, Yang RC, Chen MY, Pang JH. Phyllanthus urinaria induces the Fas receptor/ligand expression and ceramide-mediated apoptosis in HL-60 cells. Life Sci 2004;75:339-51. [PMID: 15135654 DOI: 10.1016/j.lfs.2003.12.013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
367 Chipuk JE, Maurer U, Green DR, Schuler M. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 2003;4:371-81. [PMID: 14667504 DOI: 10.1016/s1535-6108(03)00272-1] [Cited by in Crossref: 198] [Cited by in F6Publishing: 178] [Article Influence: 11.0] [Reference Citation Analysis]
368 Eichhorst ST, Krueger A, Müerköster S, Fas SC, Golks A, Gruetzner U, Schubert L, Opelz C, Bilzer M, Gerbes AL, Krammer PH. Suramin inhibits death receptor–induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat Med 2004;10:602-9. [DOI: 10.1038/nm1049] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 3.3] [Reference Citation Analysis]
369 Chi T, Chen GG, Lai PBS. Eicosapentaenoic Acid Induces Fas-Mediated Apoptosis Through a p53-Dependent Pathway in Hepatoma Cells: . The Cancer Journal 2004;10:190-200. [DOI: 10.1097/00130404-200405000-00009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
370 Schneider-Stock R, Mawrin C, Motsch C, Boltze C, Peters B, Hartig R, Buhtz P, Giers A, Rohrbeck A, Freigang B, Roessner A. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol 2004;164:1233-41. [PMID: 15039212 DOI: 10.1016/S0002-9440(10)63211-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
371 Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 2004;195:298-308. [PMID: 15020192 DOI: 10.1016/j.taap.2003.08.019] [Cited by in Crossref: 784] [Cited by in F6Publishing: 804] [Article Influence: 43.6] [Reference Citation Analysis]
372 Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ, El-Deiry WS. BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol. 2002;4:842-849. [PMID: 12402042 DOI: 10.1038/ncb866] [Cited by in Crossref: 296] [Cited by in F6Publishing: 305] [Article Influence: 16.4] [Reference Citation Analysis]
373 Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev. 2003;193:70-81. [PMID: 12752672 DOI: 10.1034/j.1600-065x.2003.00051.x] [Cited by in Crossref: 432] [Cited by in F6Publishing: 451] [Article Influence: 24.0] [Reference Citation Analysis]
374 Schulze-Bergkamen H, Krammer PH. Apoptosis in cancer--implications for therapy. Semin Oncol. 2004;31:90-119. [PMID: 14970941 DOI: 10.1053/j.seminoncol.2003.11.006] [Cited by in Crossref: 98] [Cited by in F6Publishing: 104] [Article Influence: 5.4] [Reference Citation Analysis]
375 Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Kishihara K, Hirakata H, Iida M. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 2003;63:72-82. [PMID: 12472770 DOI: 10.1046/j.1523-1755.2003.00709.x] [Cited by in Crossref: 174] [Cited by in F6Publishing: 180] [Article Influence: 9.7] [Reference Citation Analysis]
376 Yamauchi H, Katayama K, Ueno M, Uetsuka K, Nakayama H, Doi K. Involvement of p53 in 1-beta-D-arabinofuranosylcytosine-induced trophoblastic cell apoptosis and impaired proliferation in rat placenta. Biol Reprod 2004;70:1762-7. [PMID: 14766721 DOI: 10.1095/biolreprod.103.026252] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
377 Roos W, Baumgartner M, Kaina B. Apoptosis triggered by DNA damage O6-methylguanine in human lymphocytes requires DNA replication and is mediated by p53 and Fas/CD95/Apo-1. Oncogene. 2004;23:359-367. [PMID: 14724564 DOI: 10.1038/sj.onc.1207080] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 5.4] [Reference Citation Analysis]
378 Dunkern T, Roos W, Kaina B. Apoptosis induced by MNNG in human TK6 lymphoblastoid cells is p53 and Fas/CD95/Apo-1 related. Mutat Res. 2003;544:167-172. [PMID: 14644318 DOI: 10.1016/j.mrrev.2003.06.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
379 Merritt RE, Mahtabifard A, Yamada RE, Crystal RG, Korst RJ. Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer. J Thorac Cardiovasc Surg 2003;126:1609-17. [PMID: 14666041 DOI: 10.1016/s0022-5223(03)00707-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
380 Fleischer A, Rebollo A. Induction of p53-independent apoptosis by the BH3-only protein ITM2Bs. FEBS Letters 2004;557:283-7. [DOI: 10.1016/s0014-5793(03)01519-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
381 Schulte-hermann R, Parzefall W. Mehrstufenprozess der Kanzerogenese und chemische Kanzerogenese. Die Onkologie 2004. [DOI: 10.1007/978-3-662-06670-6_7] [Reference Citation Analysis]
382 Asker C, Bykov VJN, Mendez-vidal C, Selivanova G, Wilhelm MT, Wiman KG. The p53 Transcription Factor as Therapeutic Target in Cancer. Transcription Factors 2004. [DOI: 10.1007/978-3-642-18932-6_7] [Reference Citation Analysis]
383 Williams SA, Mcconkey DJ. Proteasome Inhibition and Apoptosis. Proteasome Inhibitors in Cancer Therapy 2004. [DOI: 10.1007/978-1-59259-794-9_7] [Reference Citation Analysis]
384 Holmes WF, Soprano DR, Soprano KJ. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines. J Cell Physiol 2004;199:317-29. [DOI: 10.1002/jcp.10338] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
385 Ozoren N, El-Deiry WS. Cell surface Death Receptor signaling in normal and cancer cells. Semin Cancer Biol. 2003;13:135-147. [PMID: 12654257 DOI: 10.1016/S1044-579X(02)00131-1] [Cited by in Crossref: 222] [Cited by in F6Publishing: 230] [Article Influence: 11.7] [Reference Citation Analysis]
386 Ruiz de Almodóvar C, Ruiz-Ruiz C, Rodríguez A, Ortiz-Ferrón G, Redondo JM, López-Rivas A. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site. J Biol Chem. 2004;279:4093-4101. [PMID: 14623878 DOI: 10.1074/jbc.M311243200] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
387 Itoh K, Hase H, Kojima H, Saotome K, Nishioka K, Kobata T. Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts. Rheumatology 2004;43:277-85. [DOI: 10.1093/rheumatology/keh039] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
388 Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. J Pathol. 2003;201:268-277. [PMID: 14517844 DOI: 10.1002/path.1428] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 3.6] [Reference Citation Analysis]
389 Medina J, Picarles V, Greiner B, Elsaesser C, Kolopp M, Mahl A, Roman D, Vogel B, Nussbaumer P, Winiski A, Meingassner J, Fraissinette ADBD. LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis. Biochemical Pharmacology 2003;66:1885-95. [DOI: 10.1016/s0006-2952(03)00369-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
390 Sax JK, El-Deiry WS. p53 downstream targets and chemosensitivity. Cell Death Differ 2003;10:413-7. [PMID: 12719718 DOI: 10.1038/sj.cdd.4401227] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 4.5] [Reference Citation Analysis]
391 Rajesh D, Howard SP. Perillyl alcohol mediated radiosensitization via augmentation of the Fas pathway in prostate cancer cells. Prostate 2003;57:14-23. [PMID: 12886519 DOI: 10.1002/pros.10269] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
392 Zalcenstein A, Stambolsky P, Weisz L, Müller M, Wallach D, Goncharov TM, Krammer PH, Rotter V, Oren M. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants. Oncogene 2003;22:5667-76. [PMID: 12944915 DOI: 10.1038/sj.onc.1206724] [Cited by in Crossref: 87] [Cited by in F6Publishing: 93] [Article Influence: 4.6] [Reference Citation Analysis]
393 Wenzel U, Kuntz S, De Sousa UJ, Daniel H. Nitric oxide suppresses apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Int J Cancer 2003;106:666-75. [PMID: 12866025 DOI: 10.1002/ijc.11294] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 2.7] [Reference Citation Analysis]
394 Iwase M, Watanabe H, Kondo G, Ohashi M, Nagumo M. Enhanced susceptibility of oral squamous cell carcinoma cell lines to FAS-mediated apoptosis by cisplatin and 5-fluorouracil. Int J Cancer 2003;106:619-25. [PMID: 12845662 DOI: 10.1002/ijc.11239] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
395 Yeon JE, Califano S, Xu J, Wands JR, De La Monte SM. Potential role of PTEN phosphatase in ethanol-impaired survival signaling in the liver. Hepatology 2003;38:703-14. [PMID: 12939597 DOI: 10.1053/jhep.2003.50368] [Cited by in Crossref: 82] [Cited by in F6Publishing: 91] [Article Influence: 4.3] [Reference Citation Analysis]
396 Tsuruya K, Tokumoto M, Ninomiya T, Hirakawa M, Masutani K, Taniguchi M, Fukuda K, Kanai H, Hirakata H, Iida M. Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways. American Journal of Physiology-Renal Physiology 2003;285:F208-18. [DOI: 10.1152/ajprenal.00311.2002] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 4.3] [Reference Citation Analysis]
397 Ramp U, Caliskan E, Mahotka C, Krieg A, Heikaus S, Gabbert HE, Gerharz CD. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage. Br J Cancer. 2003;88:1800-1807. [PMID: 12771998 DOI: 10.1038/sj.bjc.6600984] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
398 Lasham A, Moloney S, Hale T, Homer C, Zhang YF, Murison JG, Braithwaite AW, Watson J. The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor. J Biol Chem. 2003;278:35516-35523. [PMID: 12835324 DOI: 10.1074/jbc.M303920200] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 4.2] [Reference Citation Analysis]
399 Spierings DCJ, de Vries EGE, Vellenga E, de Jong S. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line. Cell Death Differ 2003;10:808-22. [DOI: 10.1038/sj.cdd.4401248] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 2.7] [Reference Citation Analysis]
400 Wosik K, Antel J, Kuhlmann T, Brück W, Massie B, Nalbantoglu J. Oligodendrocyte injury in multiple sclerosis: a role for p53. J Neurochem 2003;85:635-44. [PMID: 12694389 DOI: 10.1046/j.1471-4159.2003.01674.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 3.3] [Reference Citation Analysis]
401 Rajesh D, Stenzel RA, Howard SP. Perillyl alcohol as a radio-/chemosensitizer in malignant glioma. J Biol Chem 2003;278:35968-78. [PMID: 12805388 DOI: 10.1074/jbc.M303280200] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
402 Sax JK, El-Deiry WS. Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene. J Biol Chem 2003;278:36435-44. [PMID: 12788948 DOI: 10.1074/jbc.M303191200] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 2.4] [Reference Citation Analysis]
403 Ruiz-Ruiz C, Robledo G, Cano E, Redondo JM, Lopez-Rivas A. Characterization of p53-mediated up-regulation of CD95 gene expression upon genotoxic treatment in human breast tumor cells. J Biol Chem 2003;278:31667-75. [PMID: 12788915 DOI: 10.1074/jbc.M304397200] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
404 Schulze-Bergkamen H, Untergasser A, Dax A, Vogel H, Büchler P, Klar E, Lehnert T, Friess H, Büchler MW, Kirschfink M, Stremmel W, Krammer PH, Müller M, Protzer U. Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection. J Hepatol 2003;38:736-44. [PMID: 12763365 DOI: 10.1016/s0168-8278(03)00120-x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 4.4] [Reference Citation Analysis]
405 Backus H, Wouters D, Ferreira C, van Houten V, Brakenhoff R, Pinedo H, Peters G. Thymidylate synthase inhibition triggers apoptosis via caspases-8 and -9 in both wild-type and mutant p53 colon cancer cell lines. European Journal of Cancer 2003;39:1310-7. [DOI: 10.1016/s0959-8049(03)00204-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
406 Ashe PC, Berry MD. Apoptotic signaling cascades. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:199-214. [PMID: 12657360 DOI: 10.1016/S0278-5846(03)00016-2] [Cited by in Crossref: 120] [Cited by in F6Publishing: 107] [Article Influence: 6.3] [Reference Citation Analysis]
407 Samel D, Muller D, Gerspach J, Assohou-Luty C, Sass G, Tiegs G, Pfizenmaier K, Wajant H. Generation of a FasL-based proapoptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted Activation. J Biol Chem 2003;278:32077-82. [PMID: 12773535 DOI: 10.1074/jbc.M304866200] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 3.1] [Reference Citation Analysis]
408 Liedtke C, Groger N, Manns MP, Trautwein C. The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism. J Biol Chem 2003;278:27593-604. [PMID: 12748179 DOI: 10.1074/jbc.M304077200] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 3.2] [Reference Citation Analysis]
409 Schuler M, Maurer U, Goldstein JC, Breitenbücher F, Hoffarth S, Waterhouse NJ, Green DR. p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation. Cell Death Differ 2003;10:451-60. [DOI: 10.1038/sj.cdd.4401180] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 4.2] [Reference Citation Analysis]
410 Shimada K, Nakamura M, Ishida E, Kishi M, Yonehara S, Konishi N. c-Jun NH2-terminal kinase-dependent fas activation contributes to etoposide-induced apoptosis in p53-mutated prostate cancer cells. Prostate 2003;55:265-80. [DOI: 10.1002/pros.10227] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
411 Ramp U, Bretschneider U, Ebert T, Karagiannidis C, Willers R, Gabbert HE, Gerharz CD. Prognostic implications of CD95 receptor expression in clear cell renal carcinomas. Hum Pathol 2003;34:174-9. [PMID: 12612886 DOI: 10.1053/hupa.2003.46] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
412 Tímár J, Ladányi A, Peták I, Jeney A, Kopper L. Molecular pathology of tumor metastasis III: Target array and combinatorial therapies. Pathol Oncol Res 2003;9:49-72. [DOI: 10.1007/bf03033715] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
413 Pirnia F, Schneider E, Betticher DC, Borner MM. Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ. 2002;9:905-914. [PMID: 12181741 DOI: 10.1038/sj.cdd.4401062] [Cited by in Crossref: 101] [Cited by in F6Publishing: 109] [Article Influence: 5.3] [Reference Citation Analysis]
414 Tomasini R, Samir AA, Pebusque MJ, Calvo EL, Totaro S, Dagorn JC, Dusetti NJ, Iovanna JL. P53-dependent expression of the stress-induced protein (SIP). Eur J Cell Biol. 2002;81:294-301. [PMID: 12067065 DOI: 10.1078/0171-9335-00248] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 3.2] [Reference Citation Analysis]
415 Tomicic MT, Friedrichs C, Christmann M, Wutzler P, Thust R, Kaina B. Apoptosis Induced by ( E )-5-(2-Bromovinyl)-2′-deoxyuridine in Varicella Zoster Virus Thymidine Kinase-Expressing Cells Is Driven by Activation of c-Jun/Activator Protein-1 and Fas Ligand/Caspase-8. Mol Pharmacol 2003;63:439-49. [DOI: 10.1124/mol.63.2.439] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
416 Maggio EM, Van Den Berg A, de Jong D, Diepstra A, Poppema S. Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma. Am J Pathol 2003;162:29-35. [PMID: 12507887 DOI: 10.1016/S0002-9440(10)63795-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.3] [Reference Citation Analysis]
417 Kim KM, Kim HW, Kim JO, Baek KM, Kim JG, Kang CY. Induction of 4-1BB (CD137) expression by DNA damaging agents in human T lymphocytes. Immunology 2002;107:472-9. [PMID: 12460192 DOI: 10.1046/j.1365-2567.2002.01538.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
418 Kuwano K, Hagimoto N, Maeyama T, Fujita M, Yoshimi M, Inoshima I, Nakashima N, Hamada N, Watanabe K, Hara N. Mitochondria-mediated apoptosis of lung epithelial cells in idiopathic interstitial pneumonias. Lab Invest 2002;82:1695-706. [PMID: 12480919 DOI: 10.1097/01.lab.0000045084.81853.76] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
419 Spierings DC, de Vries EG, Vellenga E, de Jong S. The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuli. J Pathol 2003;200:137-48. [DOI: 10.1002/path.1373] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
420 Dunkern TR, Wedemeyer I, Baumgärtner M, Fritz G, Kaina B. Resistance of p53 knockout cells to doxorubicin is related to reduced formation of DNA strand breaks rather than impaired apoptotic signaling. DNA Repair 2003;2:49-60. [DOI: 10.1016/s1568-7864(02)00185-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
421 Eichhorst ST, Krammer PH. Apoptose. Grundlagen der Molekularen Medizin 2003. [DOI: 10.1007/978-3-662-07588-3_7] [Reference Citation Analysis]
422 Chen YH. Apoptosis and Autoimmune Diseases. Molecular Mechanisms of Programmed Cell Death 2003. [DOI: 10.1007/978-1-4757-5890-0_6] [Reference Citation Analysis]
423 Guicciardi ME, Gores GJ. The Death Receptor Family and the Extrinsic Pathway. Essentials of Apoptosis 2003. [DOI: 10.1007/978-1-59259-361-3_5] [Reference Citation Analysis]
424 Ruiz de Almodóvar C, López-Rivas A, Redondo JM, Rodríguez A. Transcription initiation sites and promoter structure of the human TRAIL-R3 gene. FEBS Lett 2002;531:304-8. [PMID: 12417331 DOI: 10.1016/s0014-5793(02)03544-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
425 Ueno M, Katayama K, Nakayama H, Doi K. Mechanisms of 5-azacytidine (5AzC)-induced toxicity in the rat foetal brain. Int J Exp Pathol 2002;83:139-50. [PMID: 12383193 DOI: 10.1046/j.1365-2613.2002.00225.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
426 Siegmund D, Hadwiger P, Pfizenmaier K, Vornlocher H, Wajant H. Selective Inhibition of FLICE-like Inhibitory Protein (FLIP) Expression With Small Interfering RNA Oligonucleotides (siRNAs) Is Sufficient to Sensitize Tumor Cells for TRAIL-Induced Apoptosis. Mol Med 2002;8:725-32. [DOI: 10.1007/bf03402036] [Cited by in Crossref: 88] [Cited by in F6Publishing: 44] [Article Influence: 4.4] [Reference Citation Analysis]
427 Zhao AG, Zhao HL, Jin XJ, Yang JK, Tang LD. Effects of Chinese Jianpi herbs on cell apoptosis and related gene expression in human gastric cancer grafted onto nude mice. World J Gastroenterol 2002; 8(5): 792-796 [PMID: 12378617 DOI: 10.3748/wjg.v8.i5.792] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 42] [Article Influence: 1.9] [Reference Citation Analysis]
428 Lim YS, So HS, Kim MS, Moon G, Won JH, Baek SW, Moon SR, Yang SH, Kim BJ, Ko CB, Park R. Palgin sensitizes the adriamycin-induced apoptosis via the enhancement of Fas/Fas ligand expression. Life Sci 2002;71:2391-401. [PMID: 12231400 DOI: 10.1016/s0024-3205(02)02039-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
429 Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N. A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF). FEBS Lett 2002;524:163-71. [PMID: 12135761 DOI: 10.1016/s0014-5793(02)03049-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 3.3] [Reference Citation Analysis]
430 Ravi R, Bedi A. Potential methods to circumvent blocks in apoptosis in lymphomas: . Current Opinion in Oncology 2002;14:490-503. [DOI: 10.1097/00001622-200209000-00004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
431 Daniely Y, Dimitrova DD, Borowiec JA. Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation. Mol Cell Biol 2002;22:6014-22. [PMID: 12138209 DOI: 10.1128/MCB.22.16.6014-6022.2002] [Cited by in Crossref: 122] [Cited by in F6Publishing: 128] [Article Influence: 6.1] [Reference Citation Analysis]
432 Löber C, Lenz-Stöppler C, Dobbelstein M. Adenovirus E1-transformed cells grow despite the continuous presence of transcriptionally active p53. J Gen Virol 2002;83:2047-57. [PMID: 12124469 DOI: 10.1099/0022-1317-83-8-2047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
433 Facchinetti F, Furegato S, Terrazzino S, Leon A. H(2)O(2) induces upregulation of Fas and Fas ligand expression in NGF-differentiated PC12 cells: modulation by cAMP. J Neurosci Res 2002;69:178-88. [PMID: 12111799 DOI: 10.1002/jnr.10295] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
434 Schmitt O, Schubert C, Feyerabend T, Hellwig-bürgel T, Weiss C, Kühnel W. Preferential Topography of Proteins Regulating Vascularization and Apoptosis in a MX1 Xenotransplant After Treatment With Hypoxia, Hyperthermia, Ifosfamide, and Irradiation: . American Journal of Clinical Oncology 2002;25:325-36. [DOI: 10.1097/00000421-200208000-00001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
435 Hwang SJ, Cha JY, Park SG, Joe GJ, Kim HM, Moon HB, Jeong SJ, Lee JS, Shin DH, Ko SR, Park JK. Diol- and triol-type ginseng saponins potentiate the apoptosis of NIH3T3 cells exposed to methyl methanesulfonate. Toxicol Appl Pharmacol 2002;181:192-202. [PMID: 12079428 DOI: 10.1006/taap.2002.9413] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
436 Bourdon JC, Renzing J, Robertson PL, Fernandes KN, Lane DP. Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane. J Cell Biol 2002;158:235-46. [PMID: 12135983 DOI: 10.1083/jcb.200203006] [Cited by in Crossref: 82] [Cited by in F6Publishing: 87] [Article Influence: 4.1] [Reference Citation Analysis]
437 Ahn EY, Pan G, Vickers SM, McDonald JM. IFN-gamma upregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. Int J Cancer. 2002;100:445-451. [PMID: 12115528 DOI: 10.1002/ijc.10516] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 2.9] [Reference Citation Analysis]
438 Huigsloot M, Tijdens IB, Mulder GJ, van de Water B. Differential regulation of doxorubicin-induced mitochondrial dysfunction and apoptosis by Bcl-2 in mammary adenocarcinoma (MTLn3) cells. J Biol Chem 2002;277:35869-79. [PMID: 12107157 DOI: 10.1074/jbc.M200378200] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 3.4] [Reference Citation Analysis]
439 Notarbartolo M, Cervello M, Dusonchet L, Cusimano A, D'Alessandro N. Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Lett. 2002;180:91-101. [PMID: 11911975 DOI: 10.1016/s0304-3835(01)00834-5] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 3.1] [Reference Citation Analysis]
440 Gulesserian T, Engidawork E, Yoo BC, Cairns N, Lubec G. Alteration of caspases and other apoptosis regulatory proteins in Down syndrome. J Neural Transm Suppl 2001;:163-79. [PMID: 11771741 DOI: 10.1007/978-3-7091-6262-0_13] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
441 Sreedhar AS, Pardhasaradhi BVV, Khar A, Srinivas UK. Effect of C-terminal deletion of P53 on heat induced CD95 expression and apoptosis in a rat histiocytoma. Oncogene 2002;21:4042-9. [DOI: 10.1038/sj.onc.1205504] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
442 Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277-288. [PMID: 12001989 DOI: 10.1038/nrc776] [Cited by in Crossref: 1361] [Cited by in F6Publishing: 1420] [Article Influence: 68.1] [Reference Citation Analysis]
443 Puskas F, Gergely P, Niland B, Banki K, Perl A. Differential Regulation of Hydrogen Peroxide and Fas-Dependent Apoptosis Pathways by Dehydroascorbate, the Oxidized Form of Vitamin C. Antioxidants & Redox Signaling 2002;4:357-69. [DOI: 10.1089/15230860260196164] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
444 Poulaki V, Mitsiades CS, Mitsiades N. The role of Fas and FasL as mediators of anticancer chemotherapy. Drug Resist Updat. 2001;4:233-242. [PMID: 11991678 DOI: 10.1054/drup.2001.0210] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 2.9] [Reference Citation Analysis]
445 Perfettini JL, Darville T, Dautry-Varsat A, Rank RG, Ojcius DM. Inhibition of apoptosis by gamma interferon in cells and mice infected with Chlamydia muridarum (the mouse pneumonitis strain of Chlamydia trachomatis). Infect Immun 2002;70:2559-65. [PMID: 11953396 DOI: 10.1128/IAI.70.5.2559-2565.2002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
446 Dunkern TR, Kaina B. Cell proliferation and DNA breaks are involved in ultraviolet light-induced apoptosis in nucleotide excision repair-deficient Chinese hamster cells. Mol Biol Cell 2002;13:348-61. [PMID: 11809844 DOI: 10.1091/mbc.01-05-0225] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 3.3] [Reference Citation Analysis]
447 Embree-ku M, Venturini D, Boekelheide K. Fas Is Involved in the p53-Dependent Apoptotic Response to Ionizing Radiation in Mouse Testis1. Biology of Reproduction 2002;66:1456-61. [DOI: 10.1095/biolreprod66.5.1456] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 3.4] [Reference Citation Analysis]
448 Lam V, Findley HW, Reed JC, Freedman MH, Goldenberg GJ. Comparison of DR5 and Fas expression levels relative to the chemosensitivity of acute lymphoblastic leukemia cell lines. Leukemia Research 2002;26:503-13. [DOI: 10.1016/s0145-2126(01)00162-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
449 Tomicic MT, Thust R, Kaina B. Ganciclovir-induced apoptosis in HSV-1 thymidine kinase expressing cells: critical role of DNA breaks, Bcl-2 decline and caspase-9 activation. Oncogene 2002;21:2141-53. [PMID: 11948397 DOI: 10.1038/sj.onc.1205280] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 4.5] [Reference Citation Analysis]
450 Cotter T, De Laurenzi V, Walczak H, Melino G, Schulze-Osthoff K. The European death flying circus. Cell Death Differ 2002;9:591-2. [PMID: 11973617 DOI: 10.1038/sj.cdd.4401015] [Reference Citation Analysis]
451 Oshima RG. Apoptosis and keratin intermediate filaments. Cell Death Differ 2002;9:486-92. [DOI: 10.1038/sj.cdd.4400988] [Cited by in Crossref: 135] [Cited by in F6Publishing: 144] [Article Influence: 6.8] [Reference Citation Analysis]
452 Backus HH, Van Groeningen CJ, Vos W, Dukers DF, Bloemena E, Wouters D, Pinedo HM, Peters GJ. Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases. J Clin Pathol 2002;55:206-11. [PMID: 11896073 DOI: 10.1136/jcp.55.3.206] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 2.4] [Reference Citation Analysis]
453 Kataoka T, Ito M, Budd RC, Tschopp J, Nagai K. Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells. Exp Cell Res 2002;273:256-64. [PMID: 11822881 DOI: 10.1006/excr.2001.5438] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
454 Timmer T, de Vries EG, de Jong S. Fas receptor-mediated apoptosis: a clinical application? J Pathol. 2002;196:125-134. [PMID: 11793363 DOI: 10.1002/path.1028] [Cited by in Crossref: 93] [Cited by in F6Publishing: 96] [Article Influence: 4.7] [Reference Citation Analysis]
455 Bush JA, Li G. Cancer chemoresistance: The relationship between p53 and multidrug transporters. Int J Cancer 2002;98:323-30. [DOI: 10.1002/ijc.10226] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 3.9] [Reference Citation Analysis]
456 Mcdonald ES, Windebank AJ. Cisplatin-Induced Apoptosis of DRG Neurons Involves Bax Redistribution and Cytochrome cRelease But Not fas Receptor Signaling. Neurobiology of Disease 2002;9:220-33. [DOI: 10.1006/nbdi.2001.0468] [Cited by in Crossref: 91] [Cited by in F6Publishing: 101] [Article Influence: 4.6] [Reference Citation Analysis]
457 Benchimol S. p53-dependent pathways of apoptosis. Cell Death Differ. 2001;8:1049-1051. [PMID: 11687883 DOI: 10.1038/sj.cdd.4400918] [Cited by in Crossref: 137] [Cited by in F6Publishing: 143] [Article Influence: 6.9] [Reference Citation Analysis]
458 Aguilar-Lemarroy A, Gariglio P, Whitaker NJ, Eichhorst ST, zur Hausen H, Krammer PH, Rösl F. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene. 2002;21:165-175. [PMID: 11803460 DOI: 10.1038/sj.onc.1204979] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.3] [Reference Citation Analysis]
459 Contente A, Dittmer A, Koch MC, Roth J, Dobbelstein M. A polymorphic microsatellite that mediates induction of PIG3 by p53. Nat Genet 2002;30:315-20. [PMID: 11919562 DOI: 10.1038/ng836] [Cited by in Crossref: 184] [Cited by in F6Publishing: 193] [Article Influence: 9.2] [Reference Citation Analysis]
460 Jesenberger V, Jentsch S. Deadly encounter: ubiquitin meets apoptosis. Nat Rev Mol Cell Biol 2002;3:112-21. [DOI: 10.1038/nrm731] [Cited by in Crossref: 256] [Cited by in F6Publishing: 271] [Article Influence: 12.8] [Reference Citation Analysis]
461 Sheard MA, Vojtesek B. Simian virus-40 infection inhibits DNA damage-induced enhancement of CD95 expression and function. Oncogene 2002;21:190-7. [DOI: 10.1038/sj.onc.1205043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
462 Nicholls CD, McLure KG, Shields MA, Lee PW. Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers. Implications on the dominant negative effect. J Biol Chem 2002;277:12937-45. [PMID: 11805092 DOI: 10.1074/jbc.M108815200] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 5.3] [Reference Citation Analysis]
463 Denning MF, Wang Y, Tibudan S, Alkan S, Nickoloff BJ, Qin J. Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C. Cell Death Differ 2002;9:40-52. [DOI: 10.1038/sj.cdd.4400929] [Cited by in Crossref: 154] [Cited by in F6Publishing: 160] [Article Influence: 7.7] [Reference Citation Analysis]
464 Lorenzo E, Ruiz-Ruiz C, Quesada AJ, Hernández G, Rodríguez A, López-Rivas A, Redondo JM. Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. J Biol Chem 2002;277:10883-92. [PMID: 11779855 DOI: 10.1074/jbc.M107442200] [Cited by in Crossref: 117] [Cited by in F6Publishing: 126] [Article Influence: 5.9] [Reference Citation Analysis]
465 Park SA, Choi KS, Bang JH, Huh K, Kim SU. Cisplatin-Induced Apoptotic Cell Death in Mouse Hybrid Neurons Is Blocked by Antioxidants Through Suppression of Cisplatin-Mediated Accumulation of p53 but Not of Fas/Fas Ligand. Journal of Neurochemistry 2000;75:946-53. [DOI: 10.1046/j.1471-4159.2000.0750946.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 3.2] [Reference Citation Analysis]
466 Peters GJ, Backus HHJ, Dukers DF, Van Groeningen CJ, Vos W, Bloemena E, Wouters D, Van Riel JMGH, Smid K, Pinedo HM. 5-Fluorouracil Induction of Fas and Apoptosis in Colon Cancer Patients: Relation of Clinical Outcome with Thymidylate Synthase, Mcl-1 and Rb. Chemistry and Biology of Pteridines and Folates 2002. [DOI: 10.1007/978-1-4615-0945-5_78] [Reference Citation Analysis]
467 Solary E, Droin N, Sordet O, Rebe C, Filomenko R, Wotawa A, Plenchette S, Ducoroy P. CELL DEATH PATHWAYS AS TARGETS FOR ANTICANCER DRUGS. Anticancer Drug Development. Elsevier; 2002. pp. 55-76. [DOI: 10.1016/b978-012072651-6/50005-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
468 Guimaraes D, Hainaut P. TP53: a key gene in human cancer. Biochimie 2002;84:83-93. [DOI: 10.1016/s0300-9084(01)01356-6] [Cited by in Crossref: 113] [Cited by in F6Publishing: 122] [Article Influence: 5.7] [Reference Citation Analysis]
469 Backus HHJ, Pinedo HM, Wouters D, Koudijs MC, Ferreira CG, Peters GJ. Role of P53 Status on Sensitivity to Thymidylate Synthase Inhibitors and Induction of Apoptosis. Chemistry and Biology of Pteridines and Folates 2002. [DOI: 10.1007/978-1-4615-0945-5_73] [Reference Citation Analysis]
470 Ibrahim SM, Ringel J, Schmidt C, Ringel B, Müller P, Koczan D, Thiesen HJ, Löhr M. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death. Pancreas. 2001;23:72-79. [PMID: 11451151 DOI: 10.1097/00006676-200107000-00011] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 3.0] [Reference Citation Analysis]
471 Tan G, Heqing L, Jiangbo C, Ming J, Yanhong M, Xianghe L, Hong S, Li G. Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells. Int J Cancer 2002;97:168-72. [DOI: 10.1002/ijc.1591] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
472 Beneke R, Möröy T. Inhibition of Poly(ADP-ribose) polymerase activity accelerates T-cell lymphomagenesis in p53 deficient mice. Oncogene 2001;20:8136-41. [DOI: 10.1038/sj.onc.1205056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
473 Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood. 2001;98:2603-2614. [PMID: 11675328 DOI: 10.1182/blood.v98.9.2603] [Cited by in Crossref: 565] [Cited by in F6Publishing: 585] [Article Influence: 26.9] [Reference Citation Analysis]
474 Geske FJ, Gerschenson LE. The biology of apoptosis. Hum Pathol 2001;32:1029-38. [PMID: 11679935 DOI: 10.1053/hupa.2001.28250] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 2.5] [Reference Citation Analysis]
475 Huigsloot M, Tijdens IB, Mulder GJ, van de Water B. Differential regulation of phosphatidylserine externalization and DNA fragmentation by caspases in anticancer drug-induced apoptosis of rat mammary adenocarcinoma MTLn3 cells22Abbreviations: PS, phosphatidylserine; AV, annexin V; PI, propidium iodide; LDH, lactate dehydrogenase; zVAD-fmk, benzyloxycarbonyl-Val-Ala-DL-Asp-fluoromethylketone; PKC, protein kinase C; PARP, poly(ADP) ribose polymerase; AMC, 7-amino-4-methylcoumarin; alpha-MEM, alpha minimal essential medium; and FBS, fetal bovine serum. Biochemical Pharmacology 2001;62:1087-97. [DOI: 10.1016/s0006-2952(01)00755-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
476 Boldrini L, Faviana P, Pistolesi F, Gisfredi S, Di Quirico D, Lucchi M, Mussi A, Angeletti CA, Baldinotti F, Fogli A. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer. Oncogene. 2001;20:6632-6637. [PMID: 11641789 DOI: 10.1038/sj.onc.1204727] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
477 Jones DT, Ganeshaguru K, Virchis AE, Folarin NI, Lowdell MW, Mehta AB, Prentice HG, Hoffbrand AV, Wickremasinghe RG. Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or γ radiation. Blood 2001;98:2800-7. [DOI: 10.1182/blood.v98.9.2800] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.4] [Reference Citation Analysis]
478 Brash DE, Wikonkal NM, Remenyik E, van der Horst GT, Friedberg EC, Cheo DL, van Steeg H, Westerman A, van Kranen HJ. The DNA Damage Signal for Mdm2 Regulation, Trp53 Induction, and Sunburn Cell Formation In Vivo Originates from Actively Transcribed Genes. Journal of Investigative Dermatology 2001;117:1234-40. [DOI: 10.1046/j.0022-202x.2001.01554.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
479 Dockrell DH. Apoptotic cell death in the pathogenesis of infectious diseases. J Infect 2001;42:227-34. [PMID: 11545564 DOI: 10.1053/jinf.2001.0836] [Cited by in Crossref: 57] [Cited by in F6Publishing: 63] [Article Influence: 2.7] [Reference Citation Analysis]
480 Peták I, Houghton JA. Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res. 2001;7:95-106. [PMID: 11458271 DOI: 10.1007/bf03032574] [Cited by in Crossref: 111] [Cited by in F6Publishing: 88] [Article Influence: 5.3] [Reference Citation Analysis]
481 Simbulan-Rosenthal CM, Rosenthal DS, Luo RB, Samara R, Jung M, Dritschilo A, Spoonde A, Smulson ME. Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence. Neoplasia 2001;3:179-88. [PMID: 11494111 DOI: 10.1038/sj.neo.7900155] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
482 Blatt NB, Glick GD. Signaling pathways and effector mechanisms pre-programmed cell death. Bioorg Med Chem 2001;9:1371-84. [PMID: 11408158 DOI: 10.1016/s0968-0896(01)00041-4] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 4.6] [Reference Citation Analysis]
483 Terui T, Okuyama R, Tagami H. Molecular events occurring behind ultraviolet-induced skin inflammation: . Current Opinion in Allergy and Clinical Immunology 2001;1:461-7. [DOI: 10.1097/00130832-200110000-00013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
484 Neuman MG. Apoptosis in diseases of the liver. Crit Rev Clin Lab Sci. 2001;38:109-166. [PMID: 11347718 DOI: 10.1080/20014091084182] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 4.3] [Reference Citation Analysis]
485 Backus HH, Dukers DF, van Groeningen CJ, Vos W, Bloemena E, Wouters D, van Riel JM, Smid K, Giaccone G, Pinedo HM. 5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients. Ann Oncol. 2001;12:209-216. [PMID: 11300326 DOI: 10.1023/a:1008331525368] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 2.3] [Reference Citation Analysis]
486 Sharma K, Wang RX, Zhang LY, Yin DL, Luo XY, Solomon JC, Jiang RF, Markos K, Davidson W, Scott DW. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther. 2000;88:333-347. [PMID: 11337030 DOI: 10.1016/s0163-7258(00)00096-6] [Cited by in Crossref: 140] [Cited by in F6Publishing: 145] [Article Influence: 6.7] [Reference Citation Analysis]
487 Vit J, Guillouf C, Rosselli F. Futile Caspase-8 Activation during the Apoptotic Cell Death Induced by DNA Damaging Agents in Human B-Lymphoblasts. Experimental Cell Research 2001;269:2-12. [DOI: 10.1006/excr.2001.5284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
488 Dubrez L, Coll JL, Hurbin A, Solary E, Favrot MC. Caffeine sensitizes human H358 cell line to p53-mediated apoptosis by inducing mitochondrial translocation and conformational change of BAX protein. J Biol Chem. 2001;276:38980-38987. [PMID: 11489880 DOI: 10.1074/jbc.m102683200] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 1.7] [Reference Citation Analysis]
489 Eichhorst ST, Krammer PH. Derangement of apoptosis in cancer. The Lancet 2001;358:345-6. [DOI: 10.1016/s0140-6736(01)05584-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
490 Nakamura T, Sakamoto K. Reactive oxygen species up-regulates cyclooxygenase-2, p53, and Bax mRNA expression in bovine luteal cells. Biochem Biophys Res Commun. 2001;284:203-210. [PMID: 11374891 DOI: 10.1006/bbrc.2001.4927] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 4.3] [Reference Citation Analysis]
491 Bratton SB, Cohen GM. Apoptotic death sensor: an organelle's alter ego? Trends in Pharmacological Sciences 2001;22:306-15. [DOI: 10.1016/s0165-6147(00)01718-1] [Cited by in Crossref: 126] [Cited by in F6Publishing: 113] [Article Influence: 6.0] [Reference Citation Analysis]
492 Bartke T, Siegmund D, Peters N, Reichwein M, Henkler F, Scheurich P, Wajant H. p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene. 2001;20:571-580. [PMID: 11313989 DOI: 10.1038/sj.onc.1204124] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 3.6] [Reference Citation Analysis]
493 Glazyrin AL, Adsay VN, Vaitkevicius VK, Sarkar FH. CD95-Related Apoptotic Machinery Is Functional in Pancreatic Cancer Cells: . Pancreas 2001;22:357-65. [DOI: 10.1097/00006676-200105000-00004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
494 Chung C, Wang W, Chaudry IH, Ayala A. Increased apoptosis in lamina propria B cells during polymicrobial sepsis is FasL but not endotoxin mediated. American Journal of Physiology-Gastrointestinal and Liver Physiology 2001;280:G812-8. [DOI: 10.1152/ajpgi.2001.280.5.g812] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 1.1] [Reference Citation Analysis]
495 Geske FJ, Lieberman R, Strange R, Gerschenson LE. Early stages of p53-induced apoptosis are reversible. Cell Death Differ 2001;8:182-91. [DOI: 10.1038/sj.cdd.4400786] [Cited by in Crossref: 98] [Cited by in F6Publishing: 105] [Article Influence: 4.7] [Reference Citation Analysis]
496 Sansome C, Zaika A, Marchenko ND, Moll UM. Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett 2001;488:110-5. [PMID: 11163756 DOI: 10.1016/s0014-5793(00)02368-1] [Cited by in Crossref: 124] [Cited by in F6Publishing: 134] [Article Influence: 5.9] [Reference Citation Analysis]
497 Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol. 2001;21:1297-1310. [PMID: 11158315 DOI: 10.1128/mcb.21.4.1297-1310.2001] [Cited by in Crossref: 267] [Cited by in F6Publishing: 281] [Article Influence: 12.7] [Reference Citation Analysis]
498 Fillippovich I, Sorokina N, Gatei M, Haupt Y, Hobson K, Moallem E, Spring K, Mould M, Mcguckin MA, Lavin MF, Khanna KK. Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53. Oncogene 2001;20:514-22. [DOI: 10.1038/sj.onc.1204118] [Cited by in Crossref: 94] [Cited by in F6Publishing: 102] [Article Influence: 4.5] [Reference Citation Analysis]
499 Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem. 2000;275:39435-39443. [PMID: 10993883 DOI: 10.1074/jbc.M004583200] [Cited by in Crossref: 507] [Cited by in F6Publishing: 530] [Article Influence: 24.1] [Reference Citation Analysis]
500 Roucou X, Antonsson B, Martinou J. INVOLVEMENT OF MITOCHONDRIA IN APOPTOSIS. Cardiology Clinics 2001;19:45-55. [DOI: 10.1016/s0733-8651(05)70194-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
501 Engidawork E, Gulesserian T, Yoo BC, Cairns N, Lubec G. Alteration of Caspases and Apoptosis-Related Proteins in Brains of Patients with Alzheimer's Disease. Biochemical and Biophysical Research Communications 2001;281:84-93. [DOI: 10.1006/bbrc.2001.4306] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 3.3] [Reference Citation Analysis]
502 Rodríguez-campos A, Ruiz-enríquez P, Faraudo S, Badimon L. Mitogen-Induced p53 Downregulation Precedes Vascular Smooth Muscle Cell Migration From Healthy Tunica Media and Proliferation. ATVB 2001;21:214-9. [DOI: 10.1161/01.atv.21.2.214] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
503 Izeradjene K, Revillard J, Genestier L. Inhibition of thymidine synthesis by folate analogues induces a Fas–Fas ligand-independent deletion of superantigen-reactive peripheral T cells. International Immunology 2001;13:85-93. [DOI: 10.1093/intimm/13.1.85] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
504 Schmitz I, Kirchhoff S, Krammer PH. Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol. 2000;32:1123-1136. [PMID: 11137452 DOI: 10.1016/s1357-2725(00)00048-0] [Cited by in Crossref: 175] [Cited by in F6Publishing: 188] [Article Influence: 8.3] [Reference Citation Analysis]
505 Mccarthy N, Mercer J, Bennett M. APOPTOTIC PROTEINS. Cardiology Clinics 2001;19:75-89. [DOI: 10.1016/s0733-8651(05)70196-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
506 Song J, Sapi E, Brown W, Nilsen J, Tartaro K, Kacinski BM, Craft J, Naftolin F, Mor G. Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest 2000;106:1209-20. [PMID: 11086022 DOI: 10.1172/JCI10411] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 3.6] [Reference Citation Analysis]
507 Rosenthal DS, Simbulan-rosenthal CM, Liu WF, Smulson ME. Poly(ADP-ribose) polymerase and aging. The Role of DNA Damage and Repair in Cell Aging 2001. [DOI: 10.1016/s1566-3124(01)04030-5] [Reference Citation Analysis]
508 Cristofanilli M, Hortobagyi GN. New Horizons in Treating Metastatic Disease. Clinical Breast Cancer 2001;1:276-87. [DOI: 10.3816/cbc.2001.n.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
509 Sheard MA. Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis. Int J Cancer 2001;96:213-20. [DOI: 10.1002/ijc.1020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
510 Hama-inaba H, Choi KH, Wang B, Haginoya K, Yamada T, Hayata I, Ohyama H. Fas-independent Apoptosis Induced by UVC in p53-Mutated Human Epithelial Tumor A431 Cells through Activation of Caspase-8 and JNK/SAPK. JRR;42:201-15. [DOI: 10.1269/jrr.42.201] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
511 Guan B, Yue P, Clayman GL, Sun S. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene. J Cell Physiol 2001;188:98-105. [DOI: 10.1002/jcp.1101] [Cited by in Crossref: 99] [Cited by in F6Publishing: 103] [Article Influence: 4.7] [Reference Citation Analysis]
512 Krause K, Wasner M, Reinhard W, Haugwitz U, Dohna CL, Mössner J, Engeland K. The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res 2000;28:4410-8. [PMID: 11071927 DOI: 10.1093/nar/28.22.4410] [Cited by in Crossref: 126] [Cited by in F6Publishing: 137] [Article Influence: 5.7] [Reference Citation Analysis]
513 Lackinger D, Kaina B. Primary mouse fibroblasts deficient for c-Fos, p53 or for both proteins are hypersensitive to UV light and alkylating agent-induced chromosomal breakage and apoptosis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2000;457:113-23. [DOI: 10.1016/s0027-5107(00)00133-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
514 Kim IK, Chung CW, Woo HN, Hong GS, Nagata S, Jung YK. Reconstitution of caspase-8 sensitizes JB6 cells to TRAIL. Biochem Biophys Res Commun. 2000;277:311-316. [PMID: 11032723 DOI: 10.1006/bbrc.2000.3673] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
515 Thangaraju M, Kaufmann SH, Couch FJ. BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J Biol Chem. 2000;275:33487-33496. [PMID: 10938285 DOI: 10.1074/jbc.m005824200] [Cited by in Crossref: 106] [Cited by in F6Publishing: 117] [Article Influence: 4.8] [Reference Citation Analysis]
516 Achenbach TV, Müller R, Slater EP. Bcl-2 independence of flavopiridol-induced apoptosis. Mitochondrial depolarization in the absence of cytochrome c release. J Biol Chem 2000;275:32089-97. [PMID: 10896673 DOI: 10.1074/jbc.M005267200] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 2.3] [Reference Citation Analysis]
517 van Oosten M, Rebel H, Friedberg EC, van Steeg H, van der Horst GT, van Kranen HJ, Westerman A, van Zeeland AA, Mullenders LH, de Gruijl FR. Differential role of transcription-coupled repair in UVB-induced G2 arrest and apoptosis in mouse epidermis. Proc Natl Acad Sci USA. 2000;97:11268-11273. [PMID: 11005836 DOI: 10.1073/pnas.200226697] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 3.0] [Reference Citation Analysis]
518 Eichhorst ST, Müller M, Li-Weber M, Schulze-Bergkamen H, Angel P, Krammer PH. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs. Mol Cell Biol. 2000;20:7826-7837. [PMID: 11003676 DOI: 10.1128/mcb.20.20.7826-7837.2000] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 4.5] [Reference Citation Analysis]
519 Solary E, Droin N, Bettaieb A, Corcos L, Dimanche-boitrel M, Garrido C. Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies. Leukemia 2000;14:1833-49. [DOI: 10.1038/sj.leu.2401902] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 4.5] [Reference Citation Analysis]
520 Simizu S, Shibasaki F, Osada H. Bcl-2 inhibits calcineurin-mediated Fas ligand expression in antitumor drug-treated baby hamster kidney cells. Jpn J Cancer Res 2000;91:706-14. [PMID: 10920278 DOI: 10.1111/j.1349-7006.2000.tb01003.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
521 Sun S, Yue P, Lotan R. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells. Oncogene 2000;19:4513-22. [DOI: 10.1038/sj.onc.1203810] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 2.2] [Reference Citation Analysis]
522 Shirin H, Sordillo EM, Kolevska TK, Hibshoosh H, Kawabata Y, Oh SH, Kuebler JF, Delohery T, Weghorst CM, Weinstein IB. Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1). Infect Immun. 2000;68:5321-5328. [PMID: 10948161 DOI: 10.1128/IAI.68.9.5321-5328.2000] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 2.3] [Reference Citation Analysis]
523 Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP. Mechanisms of action of methotrexate. Immunopharmacology. 2000;47:247-257. [PMID: 10878292 DOI: 10.1016/s0162-3109(00)00189-2] [Cited by in Crossref: 173] [Cited by in F6Publishing: 180] [Article Influence: 7.9] [Reference Citation Analysis]
524 Bialik S, Gottlieb T. Death at the Dead Sea. Cell Death Differ 2000;7:851-9. [DOI: 10.1038/sj.cdd.4400718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
525 Sheikh MS, Fornace AJ Jr. Death and decoy receptors and p53-mediated apoptosis. Leukemia 2000;14:1509-13. [PMID: 10942251 DOI: 10.1038/sj.leu.2401865] [Cited by in Crossref: 131] [Cited by in F6Publishing: 131] [Article Influence: 6.0] [Reference Citation Analysis]
526 Zhu J, Chen X. MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M. Mol Cell Biol 2000;20:5602-18. [PMID: 10891498 DOI: 10.1128/MCB.20.15.5602-5618.2000] [Cited by in Crossref: 80] [Cited by in F6Publishing: 89] [Article Influence: 3.6] [Reference Citation Analysis]
527 Smulson ME, Simbulan-Rosenthal CM, Boulares AH, Yakovlev A, Stoica B, Iyer S, Luo R, Haddad B, Wang ZQ, Pang T, Jung M, Dritschilo A, Rosenthal DS. Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1. Adv Enzyme Regul 2000;40:183-215. [PMID: 10828352 DOI: 10.1016/s0065-2571(99)00024-2] [Cited by in Crossref: 91] [Cited by in F6Publishing: 96] [Article Influence: 4.1] [Reference Citation Analysis]
528 Streetz K, Leifeld L, Grundmann D, Ramakers J, Eckert K, Spengler U, Brenner D, Manns M, Trautwein C. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000;119:446-60. [PMID: 10930380 DOI: 10.1053/gast.2000.9364] [Cited by in Crossref: 162] [Cited by in F6Publishing: 171] [Article Influence: 7.4] [Reference Citation Analysis]
529 Gutiérrez del Arroyo A, Gil-lamagniere C, Lazaro I, de Marco MC, Layunta I, Silva A. Involvement of p53 and interleukin 3 in the up-regulation of CD95 (APO-1/Fas) by X-ray irradiation. Oncogene 2000;19:3647-55. [DOI: 10.1038/sj.onc.1203662] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
530 Pernick NL, Biernat L, Du W, Visscher DW. Clinicopathologic Analysis of Fas, Fas Ligand, and Other Biomarkers in Locally Advanced Breast Carcinoma. Breast Journal 2000;6:233-41. [DOI: 10.1046/j.1524-4741.2000.98087.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
531 Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem. 2000;275:16202-16212. [PMID: 10821866 DOI: 10.1074/jbc.275.21.16202] [Cited by in Crossref: 640] [Cited by in F6Publishing: 683] [Article Influence: 29.1] [Reference Citation Analysis]
532 Ramp U, Dejosez M, Mahotka C, Czarnotta B, Kalinski T, Wenzel M, Lorenz I, Müller M, Krammer P, Gabbert HE, Gerharz CD. Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma. Br J Cancer 2000;82:1851-9. [PMID: 10839301 DOI: 10.1054/bjoc.2000.1155] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.3] [Reference Citation Analysis]
533 Das H, Koizumi T, Sugimoto T, Chakraborty S, Ichimura T, Hasegawa K, Nishimura R. Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR. Br J Cancer 2000;82:1682-8. [PMID: 10817504 DOI: 10.1054/bjoc.2000.1118] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 1.7] [Reference Citation Analysis]
534 de Rozieres S, Maya R, Oren M, Lozano G. The loss of mdm2 induces p53-mediated apoptosis. Oncogene 2000;19:1691-7. [PMID: 10763826 DOI: 10.1038/sj.onc.1203468] [Cited by in Crossref: 86] [Cited by in F6Publishing: 94] [Article Influence: 3.9] [Reference Citation Analysis]
535 Zhuang L, Wang B, Sauder DN. Review: Molecular Mechanism of Ultraviolet-Induced Keratinocyte Apoptosis. Journal of Interferon & Cytokine Research 2000;20:445-54. [DOI: 10.1089/10799900050023852] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 2.4] [Reference Citation Analysis]
536 Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 2000;14:981-93. [DOI: 10.1101/gad.14.8.981] [Cited by in Crossref: 220] [Cited by in F6Publishing: 224] [Article Influence: 10.0] [Reference Citation Analysis]
537 Sawa A. Neuronal cell death in Down's syndrome. J Neural Transm Suppl 1999;57:87-97. [PMID: 10666670 DOI: 10.1007/978-3-7091-6380-1_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.0] [Reference Citation Analysis]
538 Takimoto R, El-deiry WS. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 2000;19:1735-43. [DOI: 10.1038/sj.onc.1203489] [Cited by in Crossref: 271] [Cited by in F6Publishing: 275] [Article Influence: 12.3] [Reference Citation Analysis]
539 Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem. 2000;275:7337-7342. [PMID: 10702305 DOI: 10.1074/jbc.275.10.7337] [Cited by in Crossref: 424] [Cited by in F6Publishing: 440] [Article Influence: 19.3] [Reference Citation Analysis]
540 Hotchkiss RS, Tinsley KW, Hui J, Chang KC, Swanson PE, Drewry AM, Buchman TG, Karl IE. p53-Dependent and -Independent Pathways of Apoptotic Cell Death in Sepsis. J Immunol 2000;164:3675-80. [DOI: 10.4049/jimmunol.164.7.3675] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
541 Munsch D, Watanabe-Fukunaga R, Bourdon JC, Nagata S, May E, Yonish-Rouach E, Reisdorf P. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis. J Biol Chem 2000;275:3867-72. [PMID: 10660538 DOI: 10.1074/jbc.275.6.3867] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 4.1] [Reference Citation Analysis]
542 Bouvard V, Zaitchouk T, Vacher M, Duthu A, Canivet M, Choisy-rossi C, Nieruchalski M, May E. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice. Oncogene 2000;19:649-60. [DOI: 10.1038/sj.onc.1203366] [Cited by in Crossref: 145] [Cited by in F6Publishing: 151] [Article Influence: 6.6] [Reference Citation Analysis]
543 Newton K, Strasser A. Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy. J Exp Med. 2000;191:195-200. [PMID: 10620618 DOI: 10.1084/jem.191.1.195] [Cited by in Crossref: 117] [Cited by in F6Publishing: 115] [Article Influence: 5.3] [Reference Citation Analysis]
544 Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene. 1999;18:7719-7730. [PMID: 10618712 DOI: 10.1038/sj.onc.1203249] [Cited by in Crossref: 643] [Cited by in F6Publishing: 658] [Article Influence: 29.2] [Reference Citation Analysis]
545 Sheikh MS, Fornace AJ. Role of p53 family members in apoptosis. J Cell Physiol 2000;182:171-81. [DOI: 10.1002/(sici)1097-4652(200002)182:2<171::aid-jcp5>3.0.co;2-3] [Cited by in Crossref: 138] [Cited by in F6Publishing: 143] [Article Influence: 6.3] [Reference Citation Analysis]
546 Strasser A, Vaux DL. Death in the snow: report on Keystone Conference on ‘Apoptosis and Programmed Cell Death’ at Breckenridge, CO, April 6–11th 1999. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2000;1470:R1-R11. [DOI: 10.1016/s0304-419x(99)00029-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
547 Neuman MG, Cameron RG, Haber JA, Katz GG, Malkiewicz IM, Shear NH. Inducers of cytochrome P450 2E1 enhance methotrexate-induced hepatocytoxicity. Clin Biochem 1999;32:519-36. [PMID: 10614715 DOI: 10.1016/s0009-9120(99)00052-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 2.8] [Reference Citation Analysis]
548 Gonin S, Diaz-latoud C, Richard M, Ursini MV, Imbo A, Manero F, Arrigo A. p53/T-antigen complex disruption in T-antigen transformed NIH3T3 fibroblasts exposed to oxidative stress: correlation with the appearance of a Fas/APO-1/CD95 dependent, caspase independent, necrotic pathway. Oncogene 1999;18:8011-23. [DOI: 10.1038/sj.onc.1203319] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
549 Cameron R, Feuer G. Molecular Cellular and Tissue Reactions of Apoptosis and Their Modulation by Drugs. In: Cameron RG, Feuer G, editors. Apoptosis and Its Modulation by Drugs. Berlin: Springer Berlin Heidelberg; 2000. pp. 37-57. [DOI: 10.1007/978-3-642-57075-9_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
550 Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman W, Tom E, Mack D, Levine A. The Transcriptional Program following p53 Activation. Cold Spring Harbor Symposia on Quantitative Biology 2000;65:475-82. [DOI: 10.1101/sqb.2000.65.475] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
551 Neuman M, Cameron R, Shear N. Drug-Induced Apoptosis of Skin Cells and Liver. In: Cameron RG, Feuer G, editors. Apoptosis and Its Modulation by Drugs. Berlin: Springer Berlin Heidelberg; 2000. pp. 343-55. [DOI: 10.1007/978-3-642-57075-9_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
552 Houghton JA. Apoptosis and drug response: . Current Opinion in Oncology 1999;11:475. [DOI: 10.1097/00001622-199911000-00008] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 3.8] [Reference Citation Analysis]
553 Asker C, Wiman KG, Selivanova G. p53-Induced Apoptosis as a Safeguard against Cancer. Biochemical and Biophysical Research Communications 1999;265:1-6. [DOI: 10.1006/bbrc.1999.1446] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 2.3] [Reference Citation Analysis]
554 Hsu SC, Gavrilin MA, Lee HH, Wu CC, Han SH, Lai MZ. NF-kappa B-dependent Fas ligand expression. Eur J Immunol 1999;29:2948-56. [PMID: 10508269 DOI: 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 2.3] [Reference Citation Analysis]
555 Fernandez-figueras M, Armengol P, Puig L, Molinero JL, Esquius M, Sirera G, Ariza A. Absence of Fas (CD95) and FasL (CD95L) immunohistochemical expression suggests Fas/FasL-mediated apoptotic signal is not relevant in cutaneous Kaposi's sarcoma lesions. J Cutan Pathol 1999;26:417-23. [DOI: 10.1111/j.1600-0560.1999.tb01868.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
556 Waring P, Müllbacher A. Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol 1999;77:312-7. [PMID: 10457197 DOI: 10.1046/j.1440-1711.1999.00837.x] [Cited by in Crossref: 203] [Cited by in F6Publishing: 212] [Article Influence: 8.8] [Reference Citation Analysis]
557 Roux PP, Colicos MA, Barker PA, Kennedy TE. p75 neurotrophin receptor expression is induced in apoptotic neurons after seizure. J Neurosci 1999;19:6887-96. [PMID: 10436046 [PMID: 10436046 DOI: 10.1523/jneurosci.19-16-06887.1999] [Cited by in Crossref: 152] [Cited by in F6Publishing: 152] [Article Influence: 6.6] [Reference Citation Analysis]
558 Beltinger C, Fulda S, Kammertoens T, Meyer E, Uckert W, Debatin KM. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc Natl Acad Sci U S A 1999;96:8699-704. [PMID: 10411938 DOI: 10.1073/pnas.96.15.8699] [Cited by in Crossref: 118] [Cited by in F6Publishing: 127] [Article Influence: 5.1] [Reference Citation Analysis]
559 Offer H, Wolkowicz R, Matas D, Blumenstein S, Livneh Z, Rotter V. Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. FEBS Lett 1999;450:197-204. [PMID: 10359074 DOI: 10.1016/s0014-5793(99)00505-0] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 4.0] [Reference Citation Analysis]
560 Ricci MS, El-deiry WS. The Extrinsic Pathway of Apoptosis. In: Gewirtz DA, Holt SE, Grant S, editors. Apoptosis, Senescence, and Cancer. Totowa: Humana Press; 2007. pp. 31-54. [DOI: 10.1007/978-1-59745-221-2_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
561 Fulda S, Debatin K. Death Receptor Pathways As Targets for Anticancer Therapy. In: Los M, Gibson SB, editors. Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases. New York: Springer-Verlag; 2005. pp. 57-78. [DOI: 10.1007/0-387-23695-3_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
562 Hallgren O, Aits S, Brest P, Gustafsson L, Mossberg A, Wullt B, Svanborg C. Apoptosis and Tumor Cell Death in Response to HAMLET (Human α-Lactalbumin Made Lethal to Tumor Cells). In: Bösze Z, editor. Bioactive Components of Milk. New York: Springer; 2008. pp. 217-40. [DOI: 10.1007/978-0-387-74087-4_8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Reference Citation Analysis]
563 Wesselborg S, Lauber K. Mechanisms of Anticancer Drug Action. In: Los M, Gibson SB, editors. Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases. New York: Springer-Verlag; 2005. pp. 31-55. [DOI: 10.1007/0-387-23695-3_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
564 Yang L. Mechanisms of Apoptosis Resistance In Breast Cancer. In: Piccart MJ, Hung M, Solin LJ, Cardoso F, Wood WC, editors. Breast Cancer and Molecular Medicine. Berlin: Springer Berlin Heidelberg; 2006. pp. 841-58. [DOI: 10.1007/978-3-540-28266-2_39] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
565 Siddik ZH. Cisplatin Resistance. In: Teicher BA, editor. Cancer Drug Resistance. Totowa: Humana Press; 2006. pp. 283-307. [DOI: 10.1007/978-1-59745-035-5_16] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Reference Citation Analysis]